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6ABSTRACT
Ascending cerebral dopaminergic pathways are believed to be crucial in mediating the
reinforcing effects of drugs of abuse. Virtually all drugs abused by humans increase dopamine
release in the nucleus accumbens, and this results in locomotor stimulation in experimental
animals. Repeated treatment with drugs of abuse induces behavioural and neurochemical
sensitization, i.e. the stimulatory effects of the drugs on motor activity and dopamine release are
enhanced. The data available suggest that neural mechanisms underlying sensitization are
important factors in the development of drug addiction.
Experimental animals and humans differ in their vulnerability to drug dependence, this
variability being is at least partially determined by hereditary factors. For instance, alcohol-
preferring Alko, Alcohol- (AA) rats prefer 10 % alcohol solution over plain water, while
alcohol-avoiding Alko-Non Alcohol (ANA) rats prefer water. The AA rats also consume more
aqueous solutions of cocaine and etonitazene, a µ-opioid receptor agonist, than the ANA rats.
Hence, the brain reinforcement pathways in the AA rats may be sensitive to alcohol and other
drugs of abuse. This property could well contribute to the large alcohol consumption in these
animals.
The first aim of the present study was to validate the use of the dopamine metabolite 3-
methoxytyramine (3-MT), for the assessment of dopamine release in the brain. The main aim
was to explore, with biochemical (neurotransmitter release and metabolism) and behavioural
(motor activity) methods, whether different drugs of abuse (alcohol, cocaine and morphine)
regulate those brain neurotransmitter mechanisms involved in reinforcement, especially the
dopaminergic neurons, differently in the AA and ANA rats.
The results showed that when post mortem changes in 3-MT concentrations were prevented with
brain-focused microwave irradiation, the dopamine release in the brain could be estimated by
assessing 3-MT concentrations. Of the dopamine metabolites measurable in the brain, 3-MT was
found to be most labile index of sensitization of the dopaminergic system following repeated
morphine treatment.
Intraperitoneal injection of alcohol did not increase dopamine release or motor activity in the AA
or ANA rats. Voluntary alcohol drinking enhanced dopamine release selectively in the nucleus
accumbens and olfactory tubercle in the AA rats. Alcohol drinking enhanced dopamine release
also in the caudate-putamen, but a similar increase was found in the animals given plain water
instead of alcohol. Acute treatment with morphine, a µ-opioid receptor agonist, induced stronger
locomotor stimulation in the AA rats than in the ANA rats, while the acute effects of cocaine
were similar in  both strains. Repeated morphine or cocaine induced sensitization to the
stimulatory effects of these drugs in the AA but not in the ANA rats. Acute treatment with
morphine elevated the metabolism and release of dopamine more in the caudate-putamen of the
AA rats than in the ANA rats, while no differences were found in the nucleus accumbens.
The results suggest that voluntarily consumed and intraperitoneally administered alcohol alter
dopamine function in the brain in different ways, only voluntarily consumed alcohol being
reinforcing in rats. The opioidergic activation of the nigrostriatal dopamine pathway may play a
role in the rapid learning of alcohol drinking behaviour in the AA rats. Furthermore, neuronal
mechanisms mediating reinforcement may be exceptionally susceptible to the sensitizing effects
of the drugs of abuse, including opioids, in the AA rats. Since alcohol is believed to mediate its
reinforcing effects partly via brain opioid systems, it is possible that this trait contributes to the
high alcohol intake of the AA rats. These results support the hypothesis that propensity to drug-
induced sensitization plays a role in individual susceptibility to substance abuse.
Keywords: Dopamine, 3-Methoxytyramine, opioids, AA rats, ANA rats, morphine, cocaine,
locomotor activity, alcoholism, drug dependence, striatum, caudate-putamen, nucleus
accumbens.
7ABBREVIATIONS
3-MT = 3-methoxytyramine
5-HIAA = 5-hydroxyindolacetic acid
5-HT = 5-hydroxytryptamine
AA = Alko, Alcohol
Acb = nucleus accumbens
ANA = Alko, Non-Alcohol
BAC = blood alcohol concentration
COMT = catechol-O-methyltransferase
CPu = caudate-putamen (dorsal striatum)
DOPA = 3,4-dihydroxyphenylalanine
DOPAC = 3,4-diyhydroxyphenylacetic acid
GABA = γ-aminobutyric acid
GP = globus pallidus
HVA = homovanillic acid
mfb = medial forebrain bundle
mRNA = messenger ribonucleic acid
NMDA = N-methyl-D-aspartate
PPTg = pedunculopontine tegmental nucleus
PFC = prefrontal cortex
SNc = substantia nigra pars compacta
SNr = substantia nigra pars reticulata
VP = ventral pallidum
VTA = ventral tegmenta area
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91. INTRODUCTION
Excessive alcohol (ethanol) consumption has always been and still remains the most severe
addiction problem in Finland, while abuse of other drugs such as heroin, amphetamine and
cocaine has not been as significant. However, during recent years the availability of these drugs
as well as their new derivatives has increased dramatically in our country. While the supply of
the drugs of abuse increases and more and more people start to be “exposed” to these substances,
the number of people who are likely to succumb to drug dependence increases.
Availability of the drugs, drug abuse within the family and elsewhere in community as well as
attitudes to drug abuse in the society are important factors in controlling the probability of an
individual’s first experiments with drugs of abuse (Goldstein 1994). However, it has become
evident that individuals differ also in their susceptibility to the development of drug dependence
(Pickens et al. 1996). This variability is probably partly due to environmental factors such as
prolonged exposure to stress, but is also clearly regulated by hereditary factors. This means that
some people may be especially prone to drug dependence following even brief and occasional
use due to their genetic predisposition.
Several neurobiological and behavioural traits can be involved in this propensity to drug
addiction. Traditionally, it has been believed that the withdrawal syndrome, which follows the
abrupt cessation of drug use is the main factor in the maintenance of drug use, meaning that
addicts continue to administer drugs in order to avoid the withdrawal syndrome. Thus, enhanced
sensitivity to the withdrawal syndrome and a poor ability to cope with this aversive state might
predispose an individual to continued drug use. This view does not fit well with lack of robust
physical withdrawal symptoms after cessation of psychostimulants (e.g. cocaine and
amphetamine) though these are, nevertheless, highly addictive (Robinson and Berridge 1993;
Wise and Bozarth 1987). Furthermore, there is some evidence that intense drug craving, i.e. “the
desire to experience the effect(s) of a previously experienced psychoactive substance” (Markou
et al. 1993) does not necessarily temporally overlap with the symptoms and signs of withdrawal
from opioids or alcohol.
The early finding that healthy animals without any obvious nutritional or other physiological
needs, intensively pressed a lever to electrically stimulate some brain areas (Olds and Milner
1954) or to receive intravenous injection of different drugs (Pickens and Harris 1968; Pickens
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and Thompson 1968) suggested that factors other than the withdrawal syndrome might underlie
drug abuse. This indicated that there are mechanisms in the brain, activation of which are, most
likely, perceived as rewarding. Furthermore, drugs of abuse also share the ability to maintain
behaviour which leads to their repeated use. Therefore, it seems likely that one important
mechanism underlying drug abuse by humans might be the ability of the drugs of abuse to
activate brain reward systems, not simply to the alleviation of negative effects evoked by the
withdrawal syndrome.
Thus, another factor, which might contribute to the high susceptibility of some individuals to
develop drug dependence could be that the acute effects of a drug are strongly reinforcing in
these individuals or become such due to neuroadaptive changes following occasional drug use.
Evidence from studies both with experimental animals and humans suggest that some of the
effects of drugs, such as stimulation of motor activity and activation of certain neuronal
pathways become stronger during repeated administration (Kalivas and Stewart 1991; Robinson
and Berridge 1993). Some of the pathways which become sensitized following repeated drug
treatment are those possibly involved in these reinforcement processes.
In addition to the above aspects, it is likely that several other genetically regulated physiological
properties might be involved in the predisposition to drug dependence. Thus an important goal in
search for effective psychological and medical treatments for drug dependence is to identify and
understand the mechanisms and genetic background of these traits.
The main goal of the present study was to explore whether different drugs of abuse regulate the
brain neurotransmitter mechanisms involved in reinforcement, especially the dopaminergic
system, different ways in the rats selectively bred for high [Alko-Alcohol (AA)] and low [Alko,
Non-Alchol (ANA)] voluntary alcohol consumption. The hypothesis that genetic selection for
alcohol-preference could be associated with enhanced sensitivity of dopaminergic pathways to
stimulatory effects of alcohol or morphine was tested.  Furthermore, it was studied whether at
least partly the dopamine mediated locomotor stimulant effects of alcohol, cocaine or morphine
differ in these rat strains following acute or repeated treatment with the drugs of abuse.
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2. REVIEW OF THE LITERATURE
2.1. Ascending dopaminergic pathways
Cell bodies of the neurons forming the major ascending dopaminergic pathways are located in
the brainstem, in the substantia nigra pars compacta (SNc, A9) and ventral tegmental area (VTA,
A10) (Björklund and Lindvall 1984). The A9 neurones project mainly to the caudate-putamen or
to the dorsal striatum forming the nigrostriatal dopamine system (Björklund and Lindvall 1984;
Fuxe et al. 1985) (Fig. 2.1.). A minor component of the nigrostriatal system projects from the A8
area to the ventral putamen. The mesolimbic dopaminergic pathway is formed by neurons that
project from the A10 area to the ventral striatum, i.e. the nucleus accumbens, olfactory tubercle
and other limbic regions such as amygdala and hippocampus and septum. In addition, the A10
area sends axons to the cortical areas, e.g. to the medial, prefrontal, entorhinal and cingulate
cortex, which system is called the mesocortical dopaminergic pathway (Björklund and Lindvall
1984; Fuxe et al. 1985).
In these brain regions, dopamine binds to two main dopamine receptor subtypes, namely D1- and
D2-like receptors, both groups having subtypes, i.e. D2, D3 and D4 belonging to the D2 family and
D1 and D5 belonging the D1 family (Jackson and Westlund-Danielsson 1994). Both receptor
families are G-protein-coupled, seven times cell membrane-spanning receptors, D1-type
receptors being positively and D2-type receptors negatively coupled to adenylyl cyclase. The
distribution of the subtypes within the striatum and also throughout the projection areas of
dopaminergic pathways differs (Jaber et al. 1996).
Figure 2.1. Simplified presentation of the ascending dopaminergic pathways originating
from the substantia nigra pars compacta (SNc, A9) and the ventral tegmental area (VTA,
A10) and some of their main projection areas.
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The D1 receptor is the most ubiquitous dopamine receptor. In addition to dorsal and ventral
striatum, it is expressed in several limbic regions, hypothalamus and thalamus (Jaber et al. 1996).
In the striatum D1 receptors are expressed mainly in the GABAergic medium-size spiney
neurons projecting to the SNr. In contrast the D5 receptor is expressed at a lower level and its
mRNA is detected in the hippocampus and some thalamic nuclei.
D2 receptors are expressed in the dorsal and ventral striatum in the GABAergic neurons together
with enkephalins. D3 receptors, on the other hand are found mainly in the ventral striatum, i.e.
nucleus accumbens and olfactory tubercle. The expression of D3 receptors is low in the dorsal
striatum.. The expression of D4 receptor is low in the basal ganglia but high in the areas such as
frontal cortex, amygdala and hypothalamus (Jaber et al. 1996).
2.2. Neuronal circuitries involved in motor activity and reinforcement
Since dopamine was found to be concentrated especially into the striatum, a brain area known to
participate in the extrapyramidal motor activity, it was suggested that dopamine would be
involved in the regulation of motor functions (Carlsson 1959). Furthermore, it was suggested and
later confirmed that deficient dopaminergic function would underlie the symptoms of
Parkinson’s disease.
By means of pharmacological and lesion studies it has been found that blockade and activation
of nigrostriatal, mesolimbic and mesocortical projections, produce differential changes in
spontaneous and drug-induced motor activity (Jackson et al. 1975b; Kelly et al. 1975; Pijnenburg
and Rossum 1973). Activation of nigrostriatal dopaminergic transmission by locally applied
dopamine (Jackson et al. 1975b), amphetamine (indirect DA receptor agonist) or apomorphine
(direct agonist) (Kelly et al. 1975) induce mainly stereotyped behaviours, e.g. sniffing,
grooming, oral movements but not locomotion. In contrast, selective activation of the accumbal
dopaminergic transmission enhances locomotor activity but does not cause stereotyped
behaviour (Jackson et al. 1975a; Kelly et al. 1975; Pijnenburg and Rossum 1973). Furthermore,
lesioning nigrostriatal pathway abolishes amphetamine-induced stereotyped behaviour, while it
enhances amphetamine-induced locomotor stimulation. Selective lesions of mesolimbic system
causes opposite changes in the effects of amphetamine (Kelly et al. 1975).
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In the caudate-putamen, the dopaminergic neurons make synaptic contacts with medium-size
spiny neurons that are GABAergic but use also enkephalin, substance P and dynorphin as
neurotransmitters (Gerfen 1992; Graybiel 1990). Dopamine is thought to serve as a modulator of
glutaminergic signalling from the cortical areas through the basal ganglia (Mogenson 1987).
Critical efferents from dorsal striatum involved in the regulation of motor activity are the
GABAergic neurons projecting directly or indirectly via globus pallidus and subthalamic nucleus
to the SNr (Figure 2.2.). The SNr, in turn, sends afferents to the thalamus. These project to the
cortical areas innervating the dorsal striatum, closing the cortico-striato-pallido-thalamic loop
(Alexander and Crutcher 1990; Gerfen 1992). This circuitry is believed to be central in the
modulation of extrapyramidal motor processes and it is disturbed in Parkinson’s disease,
symptoms of which include tremor, rigidity and difficulties in the initiation of motor actions
(Carlsson and Carlsson 1990; Fuxe et al. 1985; Gerfen 1992).
Figure 2.2. Schematic presentation of the brain structures and their connections between
them involved in the regulation of psychomotor and reinforcement processes (modified
from Gerfen 1992; Pulvirenti et al. 1991; Robbins and Everitt 1996)). CPu = caudate-putamen,
GP = globus pallidus, Th = thalamus, STh = subthalamic nucleus, PPTg = Pedunculopontine
Tegmental nucleus, SNc = substantia nigra pars compacta, VTA = ventral tegmental area, PCF =
prefrontal cortex, VP = ventral pallidum, B = nucleus basalis of Meynert, LH = lateral
hypothalamus, AcbSh = nucleus accumbens, shell; AcbC = nucleus accumbens core.
Similarly to the caudate-putamen, the nucleus accumbens receives glutamatergic afferents from
some cortical areas and also from the amygdala and hippocampus (Heimer et al. 1995).
Stimulation of inputs from the amygdala and hippocampus induces locomotor stimulation, which
GP
LH
VTA
Th
STh
CPu
AcbCAcbSh
SNc/r
Hippocampus
Amygdala
PFC
VP
PPTg
B
Association- and
sensorimotor
cortexLimbic cortex
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can be blocked with dopamine receptor antagonists (Mogenson 1987). This effect of
glutamatergic activation can be enhanced by direct application of dopamine into the nucleus
accumbens.
Similarly to the dorsal striatum, accumbal dopamine is believed to have a gating function, i.e. it
regulates the information flow from the limbic structures such as amygdala and hippocampus to
the motor nuclei (Mogenson 1987). The nucleus accumbens sends afferents to the VP, which, in
turn projects, to the medial prefrontal cortex (MPC), thalamus (Th), pedunculopontine tegmental
nucleus (PPTg), which is a part of the mesencephalic locomotor region (Schaefer and Michael
1987), the medial subthalamic nucleus and SN. In the nucleus accumbens, dopamine-induced
hyperactivity is thought to be caused by its inhibitory effect on GABAergic neurons projecting to
the VP, so that the release of GABA is decreased following activation of dopamine receptors in
the nucleus accumbens (Bourdelais and Kalivas 1990; Inglis et al. 1994; Mogenson 1987). This
is thought to result in the disinhibition neurons projecting to the mediodoral thalamus to enhance
locomotor activity (Pulvirenti et al. 1991). Another output from the VP is a pathway to the PPTg,
a brain area which could further mediate the information from forebrain structures to the spinal
cord and modulate the motor behavior (Mogenson 1987).
The prefrontal cortex (PFC) is involved in the various cognitive processes such as regulation of
working memory and focused attentione and these functions are modulated by mesocortical
dopamine pathway (Barkley 1998; Le Moal and Simon 1991). However, dopamine in the PFC
plays a role in locomotor activity and reinforcement as well. For instance, attenuation of
dopaminergic tone in the PFC by 6-OHDA lesion increases the stimulatory effects of
amphetamine (Carter and Pycock 1980). These effects have been suggested to result from
disinhibition of the excitatory glutamatergic afferents projecting from the PFC to the ventral
tegmental area and nucleus accumbens (Taber and Fibiger 1995).  Furthermore, rats self-
administer cocaine into the PFC indicating that this brain area could be an important part of the
brain reward circuitry (Goeders and Smith 1983) .
2.3. Synthesis and metabolism of dopamine
Dopamine, like other catecholamine neurotransmitters, is synthesized from the amino acid
precursor, tyrosine, which has to be taken up through the blood brain barrier by a transporter into
the dopaminergic cells (Cooper et al. 1986). The first step in the synthesis of catecholamines is
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the hydroxylation of tyrosine to DOPA, by tyrosine hydroxylase, which is also the rate limiting
enzyme in the synthetic cascade (Fig. 2.3.).
In the cytoplasm of cells, DOPA decarboxylase transforms DOPA to dopamine, which is then
carried by another active transporter to synaptic vesicles, where the molecules are protected from
catabolizing enzymes. The synthesis rate of the dopamine is dependent on the activity of the
tyrosine hydroxylase, an enzyme which is under the control of many and complex mechanisms
(Feldman et al. 1997). The main short-term regulatory factors are end-product inhibition, firing
rate of the neuron and autoreceptors located in the nerve-endings. The end-product of the
dopaminergic neurons, dopamine, decreases the affinity of the enzyme’s pteridine co-factor for
tyrosine hydroxylase, which results in a decrease of enzyme activity. All of the above mentioned
mechanisms, as well as many other factors (Feldman et al. 1997),  regulate the phosphorylation
state of tyrosine hydroxylase, which is the major factor in controlling its activity.
Figure 2.3. Simplified presentation of the synthesis of dopamine and its major metabolic
routes. COMT = catechol-O-methyltransferase, MAO = monoamine oxidase, 3-MT = 3-
methoxytyramine, HVA = homovanillic acid, DOPAC = 3,4-dihydroxyphenylacetic acid.
Inside the dopaminergic cells the cytosolic dopamine is metabolized mainly by two successive
reactions (Fig. 2.3. and Fig. 2.4.). First, monoamine oxidase (MAO) transforms dopamine to a
corresponding aldehyde which then can serve as a substrate for aldehyde dehydrogenase to
produce 3,4-dihydroxyphenylacetic acid (DOPAC). DOPAC then diffuses out of the cells and
can be either conjugated to glucuronides or transformed to homovanillic acid (HVA) by
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catechol-O-methyltransferase (COMT) (Männistö et al. 1992; Westerink 1979; Westerink 1985).
A portion of MAO is located outside of the dopaminergic neurons, i.e. in the glial cells, while
COMT is found only outside dopaminergic neurons. A fraction of the released dopamine, the
size of which varies in different brain areas (Karoum et al. 1994) is first O-methylated by COMT
to 3-methoxytyramine (3-MT) and then oxidized by MAO to form HVA (Männistö et al. 1992;
Westerink 1985; Wood and Altar 1988).
2.4. 3-Methoxytyramine as an indicator of dopamine release in brain
Since COMT does not exist inside the dopaminergic neurons (Kaakkola et al. 1987; Karhunen et
al. 1995; Rivett et al. 1983; Roth 1992), all 3-MT found in the brain should be derived from
dopamine that is released from the nerve endings (fig 2.4.).
Based on this scheme, it has been suggested that the 3-MT concentration in the brain tissue (Di
Giulio et al. 1978; Kehr 1976; Kehr 1981; Wood and Altar 1988) or interstitial fluid (Brown et
al. 1991; Kuczensky and Segal 1992) would be an indicator of dopamine release. Indeed, it has
been shown that 3-MT levels in brain are elevated during electrical stimulation of the
dopaminergic neurons and after drug treatments that increase dopamine release (Wood and Altar
1988).
Fig 2.4. Metabolism of dopamine in the dopaminergic nerve terminal and synapse. DA =
dopamine, COMT = catechol-O-methyltransferase, MAO = monoamine oxidase, 3-MT = 3-
methoxytyramine, HVA = homovanillic acid, DOPAC = 3,4-dihydroxyphenylacetic acid.
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Methods such as in vivo microdialysis and voltammetry have enabled the measurement of
concentrations of extracellular neurotransmitters, such as dopamine, in awake, freely moving
animals (Lane and Blaha 1986, Di Chiara 1990). One major benefit of these methods is that they
allow comparison of drug-induced changes in dopamine release as a function of time in the same
animal, which is not possible when post mortem tissues are studied. However, utilization of post
mortem metabolite analysis from brain samples has some advantages over the methods
mentioned above. For instance, measurement of dopamine metabolites in post mortem tissues
permits the examination of dopaminergic activity simultaneously in several brain regions.
Measurement of DOPAC and HVA concentrations have been also used to assess the activity of
dopaminergic neurons (Di Giulio et al. 1978; Roffler-Tarlov et al. 1971; Westerink 1985; Wood
and Altar 1988), but it is evident that after certain drug treatments dopamine release and
formation of these acidic metabolites become dissociated (Miu et al. 1992). Since MAO exist
also inside the dopaminergic cells, a large portion of DOPAC is formed from newly synthesised
dopamine without release of dopamine to the synaptic cleft. This may occur especially during
elevated dopamine synthesis. For instance, decreasing the impulse flow in the dopaminergic
neurons by infusion of tetrodotoxin into the medial forebrain bundle elevates DOPAC and HVA
concentrations due to increased dopamine synthesis, although it decreases dopamine release
(Miu et al. 1992). On the contrary, amphetamine, cocaine and other dopamine reuptake inhibitors
induce a robust increase of extracellular dopamine levels but decrease concentrations of DOPAC
and HVA (Brown et al. 1991; Hurd et al. 1989; Westerink and Spaan 1982).
Utilisation of tissue 3-MT in measurement of dopamine release is complicated by the rapid and
massive accumulation of 3-MT in brain after death (Carlsson et al. 1974; Damsma et al. 1990;
Gonzales-Mora et al. 1989; Phebus et al. 1986), which may interfere with drug-induced changes.
In order to prevent the effect of post mortem changes, experimental animals have been sacrificed
with brain-focused microwave irradiation, which rapidly denaturate brain enzymes and prevents
the formation of 3-MT by inactivating COMT (Blank et al. 1983; Ikarashi et al. 1985; Lenox et
al. 1979). Another approach has been rapid freezing of brain tissue, which, however, is not so
suitable at least when rats are being used as experimental animals (Carlsson et al. 1974; Di
Giulio et al. 1978; Ikarashi et al. 1984; Westerink 1979).
However, despite the use of the microwave technique, the validity of measurement of steady-
state 3-MT, especially in the assessment of increased dopamine release, has been questioned in
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some situations. In studies on the effects of neuroleptics on dopamine metabolism, drugs such as
haloperidol, which blocks the pre- and postsynaptic dopamine receptors and thus increase
dopamine release, have sometimes clearly increased 3-MT concentrations (Gropetti et al. 1978;
Karoum and Egan 1992), induced only transient increase (Ponzio et al. 1981; Westerink and
Spaan 1982) or even decreased 3-MT levels (Waldmeier et al. 1981). Similarly, µ-opioid
receptor agonists have caused variable effects on 3-MT levels in rat striatum (Wood and Rao
1991; Yonehara and Clouet 1984). Drug-induced changes in extracellular 3-MT levels collected
by microdialysis, however, are qualitatively similar to changes in extracellular dopamine
indicating that 3-MT levels in brain do reflect dopamine release (Brown et al. 1991; Kuczensky
and Segal 1992; Wood et al. 1988; Yonehara and Clouet 1984).
2.5. The role of dopamine in reinforcement
Extensive research during recent decades has revealed that dopaminergic an mechanisms are
important part of the brain reward circuitry (Wise and Rompré 1989). These neuronal pathways
are believed to mediate the reinforcing effects of different stimuli which exert control over
behaviour. In operant psychology, a reinforcer is defined as a stimulus that increases the
probability of operant or instrumental responses that precede or are contingent upon the stimulus
(Robbins and Everitt 1996; Stolerman 1992). One example is animals which can learn to press a
lever in order to stimulate certain areas of their brain in operant chambers (Olds and Milner
1954). The neuronal substrates of stimulation are believed to be, at least partly the neuronal
circuitry which mediates reinforcement (Olds and Milner 1954; Wise and Rompré 1989). In the
“Biological theory of reinforcement” Glickmann and Schiff (1967) suggested that the same brain
structures e.g. medial forebrain bundle (mfb) that were found to be substrates for brain
stimulation reward also mediate the species specific sequences of approach behaviour.
According to this idea, the positive reinforcement process is reflected as forward locomotion or
as some other approach response towards a stimulus.
Research also revealed that several drugs of abuse can serve as reinforcers in an operant
situation, i.e. experimental animals learned to press a lever in order to get an intravenous
infusion of heroin or amphetamine (Ettenberg et al. 1982; Pickens and Harris 1968; Pickens and
Thompson 1968). The major neuronal systems that form the medial forebrain bundle are
dopaminergic and noradrenergic pathways (Björklund and Lindvall 1984), emphasizing the
involvement of these neurotransmitter systems in the intracranial self-stimulation (ICSS) reward.
The role of these neurotransmitters both in drug reward and ICSS has also been supported by the
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observation that psychostimulants increased release of these substances in brain, while
treatments that decrease noradrenergic and dopaminergic activity also attenuated ICSS (Fibiger
1978). However, studies, where the function of certain dopaminergic or noradrenergic pathways
were blocked pharmacologically or with selective lesions, strongly supported the role of
dopaminergic but not that of noradrenergic system as a substrate for the reinforcing effects of
drugs of abuse (Fibiger 1978; Wise and Rompré 1989).
As reviewed above, there are several dopaminergic systems in the brain and also in the medial
forebrain bundle (Björklund and Lindvall 1984). It is known that the role of these pathways in
the regulation of behaviour is different and that each subsystem also has several functions, at
least partly depending on the functional role of the neuronal systems they interact with (Amalric
and Koob 1993; Le Moal and Simon 1991; Robbins and Everitt 1996; White 1989).
If one considers the mesolimbic dopamine system’s projection areas, the nucleus accumbens has
been shown to be critically involved in mediation of reinforcing properties of both drugs of
abuse and of natural rewards such as feeding, drinking and sexual behaviour. Many different
kinds of rewards increase dopamine release in that brain area (Di Chiara and Imperato 1988a;
Kiyatkin 1995; Rosaria and Argiolas 1995), and attenuation of dopaminergic signalling in the
nucleus accumbens decreases the reinforcing properties of these stimuli in different animal
models (Ettenberg 1989; Rosaria and Argiolas 1995; Wise and Bozarth 1987). Based on these
findings it has been suggested that accumbal dopaminergic neurons would be the final common
pathway through which different reinforcers mediate their behavioural effects (Wise and Rompré
1989).
Although the mesolimbic dopamine system is now generally accepted to be central in the
reinforcing effects of various rewards, during recent years its exact role has become the subject
of intense debate (Bechara et al. 1998; Berridge and Robinson 1998; Di Chiara 1995; Salamone
1996; Schultz et al. 1997; Wise 1996). The psychomotor stimulant theory of addiction by Roy
Wise and Michael Bozarth (1987), states that the nucleus accumbens dopamine mediates the
rewarding, pleasurable or hedonistic effect of the reinforcer and blockade of dopamine receptors
antagonizes the hedonistic effects of a given reinforcer. There is, however, also plenty of
evidence in conflict with this idea. For instance, it seems that dopaminergic mechanisms are not
critically involved in alcohol or opioid-induced reinforement, since reduction of dopaminergic
tone does not always affect alcohol drinking, opioid self-administration or opioid-induced
conditioned place preference (Ettenberg et al. 1982; Gerrits and Van Ree 1996; Kiianmaa et al.
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1979; Linseman 1990; Mackey and Van Der Kooy 1985). Recent findings suggest that dopamine
does not necessarily play a pivotal role in intracranial self-stimulation reward (Garris et al.
1999). Therefore, several other views about the role of dopamine in reinforcement processes
have been put forward.
The theory formulated by Robinson and Berridge (Robinson and Berridge 1993) proposes that
dopaminergic mechanisms in the nucleus accumbens would not be necessarily central to the
subjective pleasurable effects of reinforcers. According to this idea, elevated dopaminergic tone
“attributes incentive salience” to those stimuli that are associated with dopamine release, i.e.
enhanced dopaminergic transmission make those events associated with elevated dopamine
transmission salient and wanted. Strong activation and sensitization of the dopamine system
induced by drugs would, therefore, make the drug effects pathologically attractive and wanted.
A modification from the theories involving dopamine holds that dopamine mediates incentive
reward-dependent learning (Di Chiara 1995; Schultz et al. 1997). This idea is based, for instance,
on electrophysiological experiments showing that dopaminergic neurons of the monkey will
respond to a novel, rewarding stimulus, e.g. delivery of juice. However, the activation of the
neurones fades when the animal learns to expect the reward, but subsequently, after the learning,
the environmental cues predicting the reward are able to activate nigral dopamine neurons
(Mirenowicz and Schultz 1996; Schultz et al. 1997). Thus, in the learning phase, dopamine may
serve as signal about the significance of the event.
Furthermore, van der Kooy and his associates have suggested that brain dopamine would
mediate reinforcement only in the withdrawal state, i.e. after cessation of repeated opioid
treatment or in food-deprived animals (Bechara et al. 1992; Bechara and van der Kooy 1992).
Normally other, non-dopamine mechanisms mediate positive reinforcing effects of opioids or
food etc.
In addition to its role in the control of motor behaviour,  also the nigrostriatal system is known to
be involved in certain memory and learning processes. Dorsal striatum and its dopaminergic
systems have been suggested to be central in the forming of habits or stimulus-response
association, i.e. certain sequences of motor actions are “built in” the striatal circuitry, which then
mediates learned responses to the appropriate environmental stimuli. This means that the dorsal
striatum mediates “less cognitive” but more “rigid” learning (White 1997), which is also
“impervious to fluctuations in the value of reinforcer” (Robbins and Everitt 1996). Therefore,
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also nigrostriatal dopamine system may have a role in drug reinforcement and the development
of addiction.
It is, thus, evident that dopaminergic pathways in brain are important in the regulation of certain
learning, motivational and reward processes. However, their exact role is not known, and it is
likely that ascending dopaminergic pathways have multiple roles in these functions.
2.6. Outline of brain opioid systems
Several families of opioid peptides have been identified in the mammalian central nervous
system, all of them being derived from precursors encoded by distinct genes (Darland et al.
1998; Loughlin et al. 1995; Zadina et al. 1997). Most of these peptides are known to regulate
brain dopaminergic systems. Pro-opiomelanocortin’s (POMC) postranslational processing
generate an opioid peptide β-endorphin and also adrenocorticotrophic hormone (ACTH). The
most important site for biosynthesis of POMC  (Li and Chung 1976) is the pituitary and in the
brain, POMC is synthesised in the arcuate nucleus and in the nucleus tractus solitarius. Although
there is very little POMC containing innervation to the dopaminergic neurons, some fibers have
been found in the SNc and the ventral striatum, including the nucleus accumbens and olfactory
tubercle (Khachaturian et al. 1985).
The proenkephalin (PENK) gene encodes a protein, processing of which yields four copies of
methionine-enkephalin (M-Enk) and one copy of leucine-enkephalin (L-Enk) that are the main
products of this precursor molecule (Hughes et al. 1975). With respect to dopaminergic brain
regions, enkephalinergic cell bodies and fibers have been found in the dorsal and ventral striatum
as well as in the SN (Höllt 1993; Loughlin et al. 1995).
Dynorphin A, dynorphin B and leucine-enkephalin are derived from prodynorphin (PDYN)
Localisation of PDYN synthesising neurons and peptides derived from it is fairly parallel with
that of enkephalinergic system. PDYN synthesising cell bodies are found in the amygdala,
hippocampus, cerebral cortex, hypothalamus and striatum, while nerve terminals and fibers
containing these peptides are found in the SN, globus pallidus and raphe nuclei etc. (Loughlin et
al. 1995).
Orphanin FQ or nociceptin was isolated independently by two groups in 1995 (see for review:
Darland et al. 1998) and this peptide is widely expressed in brain including dopaminergic brain
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regions (Darland et al. 1998). Two novel opioid peptides, endomorphin-1 and endomorphin-2,
were isolated from bovine brain in 1997 (Zadina et al. 1997) and found to show high affinity and
selectivity for µ-opioid receptors (see below). Endomorphin-2 is expressed in several brain
regions with known dopaminergic innervation, e.g. nucleus accumbens shell (Schreff et al.
1998).
Opioid binding sites in brain were first found by several groups independently in 1973 using
ligand binding methodology (Pert and Snyder 1973; Simon et al. 1973; Terenius 1973). At
present, four distinct subtypes of opioid receptors have been found, i.e. µ-, δ- and κ-, and orphan
receptors. All four subtypes were cloned in the beginning of the 1990’s (Chen et al. 1993;
Darland et al. 1998; Evans et al. 1992; Kieffer et al. 1992). All of these receptors are negatively
coupled to adenylyl cyclase via Gi/o protein, so the binding of agonists leads to a decrease of
cAMP concentration in target cells. However, other effects on cellular functions for opioids have
been also described, such as modulation of cation channels (Ca2+, K+) and phospholipase C
(Dhawan et al. 1996).
Table 2.1. Brain opioid peptides, their precursor molecules and preferential binding sites
Propeptide Peptide(s) Preferential receptor
POMC β-endorphin µ/δ*
Endomorphin-1
Endomorphin-2 µ
PENK Met-enkephalin
Leu-enkephalin δ
PDYN Dynorphin A
Dynorphin B κ
Pro-orphanin FQ Orphanin FQ orphan receptor
* β-endorphin binds with rather similar affinity to both δ- and µ-receptors and no clearly
preferential binding site for it has been found in the brain (Corbett et al. 1993).
µ-Receptors are widely distributed in the rat brain, and especially high concentrations are found
in the dorsal and ventral striatum, limbic structures (amygdala) and thalamic nuclei (Mansour
and Watson 1993). µ-Receptor concentrations are also high in the SNc but very sparse in the
VTA (German et al. 1993). In contrast, most of the δ-binding is seen in the rostral forebrain
23
regions, e.g. in the caudate-putamen, nucleus accumbens and amygdala (Mansour and Watson
1993). The density and distribution of κ-receptors in rat brain differs from those in several other
species, such as guinea pig, monkey and human. If one considers the dopaminergic regions, the
κ-sites are densely found in the caudate-putamen, nucleus accumbens and olfactory tubercle of
the rat but in the monkey κ-binding is low in these regions. In the SN, in the rat the κ-binding is
sparse but relatively high in the monkey.
2.7. Effects of opioids on dopamine systems and motor activity
The first evidence that cerebral dopamine systems are regulated by opioids came from
pharmacological studies showing that relatively selective µ-opioid receptor agonists such as
morphine and methadone increase turnover and metabolism of dopamine in brain (Ahtee and
Kääriäinen 1973; Clouet and Ratner 1970; Gunne et al. 1969; Laverty and Sharman 1965). For
example, morphine has been shown to increase concentrations dopamine metabolites (Ahtee and
Kääriäinen 1973; Moleman et al. 1984; Papeschi et al. 1975), increase dopamine depletion after
inhibition of tyrosine hydroxylase (Attila and Ahtee 1984a; Eidelberg and Schwartz 1970;
Gunne et al. 1969; Moleman and Bruinvels 1979) and increase the accumulation of dopa after
inhibition of DOPA decarboxylase (Kalivas and Duffy 1987).
The effects of agonists for different opioid receptor subtypes on dopamine release differ. Studies
conducted later by using in vivo methods, such as microdialysis and 3-MT accumulation, have
confirmed that µ-opioids increase extracellular levels of dopamine both in the dorsal and ventral
striatum as well as in the prefrontal cortex (Di Chiara and Imperato 1988b; Pei et al. 1993;
Shoaib et al. 1995; Wood and Rao 1991). Furthermore, local application of an enkephalinase
inhibitor into the VTA increases dopamine release in the nucleus accumbens and motor activity
of the rats, suggesting that endogenous opioids activate dopaminergic neurons (Dauge et al.
1992). Electrophysiological evidence and results from local drug injections have shown that µ-
opioids most likely cause their effects in the cell body regions, i.e. in the SN and VTA. If present
at all, there are only very small amounts of µ-receptors in the dopaminergic neurons both in the
VTA and SNc. Thus µ-Opioid agonists are thought to activate dopaminergic neurons via
inhibiting the GABAergic neurons that tonically control the firing rate of dopaminergic neurons
(Gysling and Wang 1983; Henry et al. 1992; Johnson and North 1992; Trulson and Arasteh
1985). However, the evidence from the SN is somewhat indirect (Hommer and Pert 1983;
Iwatsubo and Clouet 1977; Walker et al. 1987), since the GABA system which is believed to
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cause this disinhibition of dopaminergic neurons has not been pharmacologically characterized
in that brain region. When infused directly into the nucleus accumbens, µ-opioids increase or
have no effect on dopamine release (Mulder et al. 1989; Yokoo et al. 1994). On the other hand,
there is some evidence that activation of µ-receptors might have an inhibitory effect on
dopamine release in the caudate-putamen (Piepponen et al. 1999; Rossetti et al. 1990;
Widdowson and Holman 1992, see also: Dourmap et al. 1992).
Although the µ-opioids are mainly sedative in humans, in rats and mice they have also dose-
dependent stimulatory effects. Low doses of morphine < 2-3 mg/kg (s.c.) produce stimulation in
rats without initial sedation, while higher doses produce first sedation and even a cataleptic state.
After a certain period (depending on dose) also higher doses induce locomotor stimulation
(Babbini and Davis 1972; Oliverio and Castellano 1974; Pert and Sivit 1977). In rats, morphine-
induced acute psychomotor stimulation is seen mainly as horizontal locomotion (ambulatory
activity) though there may be some stereotyped gnawing in the later phase (Cowan 1993).
µ-Opioid-induced locomotor stimulation is thought to be mediated by dopamine, since blockade
of dopamine receptors attenuates the stimulatory effect of systemically administered morphine
(Di Chiara 1995; Di Chiara and North 1992). However, there are several other brain regions,
such as the PPTg, VP and nucleus accumbens (Austin and Kalivas 1990; Kalivas et al. 1983;
Klitenick and Kalivas 1994; Klitenick and Wirtshafter 1995), in which µ-opioids increase
locomotor activity following local infusion. At least in the nucleus accumbens, this effect of µ-
opioids is not dependent on dopamine since it is not affected by systemic administration of
neuroleptics. It has been suggested that stimulatory action of intra-accumbal opioids is mediated
via inhibition of the GABAergic pathway projecting from the nucleus accumbens to the VP
(Pulvirenti et al. 1991; Swerdlow et al. 1986). Therefore, the critical pathway underlying
locomotor stimulation induced by intra-accumbens opioids could be at least partly the same as
that involved in dopamine-mediated activation (Wise and Bozarth 1987).
There is some evidence that µ-receptor agonists may alter dopamine receptors or pathways
downstream from these receptors even after a single treatment. For instance, acute treatment with
morphine (1.0 and 10 mg/kg) sensitizes mice to the stimulatory effects of apomorphine 3 h later
(Martin and Takemori 1985). In that study, the enhanced response to apomorphine following
morphine treatment (only 10 mg/kg) was associated with increased number D2 receptor binding
sites. However, sensitivity of D2 receptors may first transiently decrease after µ-opioid treatment
as indicated by attenuated D2-agonist-induced yawning behaviour in rats following morphine
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treatment (Zharkovsky et al. 1993). Thus these results indicate that µ-opioids may modulate
behaviour also via postsynaptic dopaminergic mechanisms in addition to stimulation of
dopaminergic neurons.
Also δ-opioid receptor agonists increase dopamine metabolism and release in the dorsal and
ventral striatum (Spanagel et al. 1990; Yonehara and Clouet 1984), but their mechanisms of
action are different from those of µ-agonists. δ-Agonists can activate dopaminergic neurons in
the VTA as reflected in the increased dopamine release in the nucleus accumbens (Devine et al.
1993a). In contrast to µ-opioids, δ-agonists elevate dopamine release locally in the nucleus
accumbens and caudate-putamen (Dourmap and Costentin 1994; Dourmap et al. 1992; Lubetzki
et al. 1982). However, this effect appears to be indirect as there is no evidence that δ-receptors
would be located on the dopaminergic neurons (Le Moine et al. 1994; Pasquini et al. 1992). δ-
Agonists induce locomotor stimulation in rats and mice (Cowan 1993) and this stimulation
seems to be mediated via the dopaminergic system, since it can be antagonised by dopamine
receptor blockers (Longoni et al. 1991). However, recent evidence from experiments with non-
peptide agonists, SNC 80 and BW373U86, suggest that the stimulation induced by δ-receptor
agonists is not due to enhancement of dopamine release but is caused by the amplification of
dopaminergic transmission at the postsynaptic messenger level (Longoni et al. 1998; Pinna and
Di Chiara 1998).
κ-Receptor agonists decrease dopamine release both in the dorsal and ventral striatum (Di Chiara
and Imperato 1988b; Mulder et al. 1989). This effect is probably mediated by κ-receptors located
in the nerve terminals of the dopaminergic neurons, while in the cell body regions, κ-opioids do
not affect dopaminergic neurons (Devine et al. 1993b; Spanagel et al. 1990). In line with their
effect on dopamine release, κ-agonists decrease locomotor activity  of rats (Di Chiara and
Imperato 1988b), and they induce aversion both in the experimental animals and humans (Bals-
Kubik et al. 1993; Pfeiffer et al. 1986).
2.8. Effects of alcohol on the dopamine system and motor activity
Alcohol (ethanol) differs from many other psychoactive and abused drugs in that no specific
receptor through which it would cause its effects has been found. In addition, compared with
opioids and psychostimulants, much larger doses of alcohol are needed before any behavioural
and neurochemical effects emerge (Deitrich et al. 1989; Tabakoff et al. 1996). It was proposed
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that cell plasma membrane lipids could be a target of action of alcohol (Deitrich et al. 1989;
Tabakoff et al. 1996). However, recently it has become evident that ethanol may directly affect
the function of the proteins, e.g., by binding to certain pockets in proteins containing both
hydrophobic and hydrophilic components (Tabakoff et al. 1996).
Dopamine is one of the most thoroughly studied of the neurotransmitters affected by alcohol.
Early evidence for the possible importance of dopaminergic systems in ethanol reward was
provided by a study which showed that inhibition of dopamine synthesis with α-methyl-p-
tyrosine abolished ethanol-induced euphoria in humans (Ahlenius et al. 1973). Previously
Carlsson et al. (1972) had demonstrated that α-methyl-p-tyrosine could suppress alcohol-induced
stimulation. Furthermore Engel et al. (1974) showed that the effect of  α-methyl-p-tyrosine on
alcohol-induced stimulation could be reversed with L-dopa, suggesting that catecholamines were
central to this effect of alcohol. Subsequently, it was shown that acute administration of ethanol
(1-4 g/kg, i.p. or i.g.) accelerated dopamine metabolism and synthesis in the brains of
experimental animals such as rats and mice (Bustos and Roth 1976; Carlsson et al. 1973;
Karoum et al. 1976; Khatib et al. 1988). In a microdialysis study, Imperato and Di Chiara (1986)
found that alcohol increased extracellular dopamine levels in the caudate-putamen and nucleus
accumbens.
Data on the effects on alcohol on dopamine mechanisms in humans is scarce. A recent PET
study demonstrated that alcohol has little, if any, effect on binding of a D2 receptor ligand,
raclopride, in striatum, suggesting that alcohol (1 g/kg) does not change synaptic levels of
dopamine in man (Salonen et al. 1997). However, in that study the PET scanning was started one
hour after the last alcohol-drinking bout and during scanning the blood alcohol concentrations
(BAC) remained relatively stable. If alcohol induces its rewarding effect (dopamine release)
during the increase in the BAC (Lewis and June 1990; Risinger and Cunningham 1992), it is
likely that this phase was missed in that study.
As suggested already by Carlsson and Lindquist (1973), Imperato and Di Chiara (1986) also
demonstrated that ethanol increased dopamine release in a impulse-dependent manner as the
effect of ethanol was antagonised by γ-butyrolactone,  a drug which blocks the impulse flow in
the dopaminergic neurons. This finding is consistent with earlier results showing that
behaviourally relevant alcohol doses could increase the firing rates of dopaminergic neurons
both in the SNc and VTA in vitro and in vivo (Brodie et al. 1990; Gessa et al. 1985; Mereu and
Gessa 1985). Mereu and Gessa (1985) also showed that alcohol inhibited non-dopaminergic
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neurons in the SNr by stimulating GABAergic transmission. Since these SNr neurons are
thought to exert inhibitory effect on SNc dopaminergic neurons, the authors suggested that
alcohol-induced excitation of dopaminergic neurons and subsequent elevation of dopamine
release could occur through disinhibition, i.e. an analogous mechanism to that observed with µ-
opioid receptor agonists in the VTA.
The function of several ion channel-gated receptors is sensitive to ethanol, e.g. alcohol increases
the Cl- flux through the GABAA anion channel and K+ and Na+ flux through 5-HT3-receptor-
gated cation channels and decreases Na+ and Ca2+ influx through the NMDA-channel (Deitrich
et al. 1989; Lovinger 1991; Lovinger et al. 1989; Tabakoff et al. 1996). All these effects of
alcohol can lead to activation of dopaminergic neurons. Acute i.p. alcohol elevates also
extracellular levels of 5-HT (Yoshimoto et al. 1991) suggesting that elevated dopamine release
after alcohol might emerge indirectly via the 5-HT system. 5-HT3-receptor agonists have been
shown to activate dopaminergic neurons in the VTA (Gillies et al. 1996; Mylecherane 1996) and
antagonists of this receptor attenuate the alcohol-induced elevation of dopamine release
(Wozniak et al. 1990; Yoshimoto et al. 1991).
Furthermore, mecamylamine, an antagonist of nicotinic acetylcholine receptors, has been shown
to block alcohol-induced locomotor stimulation in mice, and increase of dopamine release
induced by intraperitoneal injection of alcohol in rats. (Blomqvist et al. 1993; Blomqvist et al.
1992). Interestingly, Ericson et al (1998) reported that infusion of mecamylamine through a
microdialysis probe into the VTA decreased alcohol drinking of rats and also prevented the
increase of dopamine release normally associated with alcohol drinking behaviour. These
findings strongly suggest that nicotinic acetylcholine receptors, especially those located in the
VTA (Blomqvist et al. 1997; Ericson et al. 1998), are involved in regulation of alcohol drinking.
There is an abundance of evidence to suggest that some of the effects of alcohol emerge via
activation of the endogenous opioid system (Herz 1997; O'Brien et al. 1996; Reid et al. 1991).
For instance alcohol-induced antinociception (Boada et al. 1981; Pohorecky and Shah 1987) and
hypothermia (Yirmiya and Taylor 1989) can be attenuated by opioid receptor antagonists,
suggesting that these effects at least partly result from the interaction of alcohol with endogenous
opioid mechanisms.
According to the current working hypothesis, alcohol stimulates the release of opioid peptides
that, in turn could stimulate those opioid receptors that control dopaminergic neurons (Herz
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1997). Increased opioidergic transmission could, thus, be responsible for alcohol’s reinforcing
effects. Evidence for the involvement of opioids in the regulation of alcohol intake has been
provided by a number of studies showing that opioid receptor antagonists reduce alcohol
drinking in both experimental animals and in humans (Altshuler et al. 1980; Hubbel et al. 1986;
O'Brien et al. 1996; Volpicelli et al. 1995). In contrast, small doses of opioid receptor agonists,
such as morphine, increase alcohol consumption in rats (Hubbel et al. 1986; Reid et al. 1991).
Furthermore, an increase in accumbal dopamine release, following intraperitoneal  (Acquas et al.
1993)  or local (Benjamin et al. 1993) alcohol-administration and voluntary alcohol drinking
(Gonzales and Weiss 1998), can be antagonized with opioid receptor antagonists.
Biochemical research has revealed that alcohol may affect brain endogenous opioid systems at
several levels (Charness 1989; Gianoulakis 1989; Tabakoff et al. 1996). Several mechanisms for
the mediation of alcohol-opioid peptide interactions have been suggested. For instance, alcohol
may affect the enzymes involved in synthesis or processing of opioid peptide precursor and
change the activity of enkephalinases, i.e. the enzymes which metabolise opioid peptides
(Gianoulakis 1989).
With respect to the acute reinforcing effects of alcohol, the most relevant alcohol-opioid
interactions sites are likely to be the hypothalamic POMC systems and the enkephalinergic
systems associated with limbic and mesolimbic dopaminergic structures. For instance, there is
evidence that alcohol increases the release of β-endorphin (or β-endorphin-like
immunoreactivity) from rat hypothalamus slices in vitro (de Waele et al. 1994; Gianoulakis
1990). Acute alcohol administration also increases plasma β-endorphin levels in mice
(Gianoulakis and Gupta 1986) and at least in human populations with a high risk for
development of alcoholism (Aguirre et al. 1995; Gianoulakis et al. 1989; Gianoulakis et al.
1996). The source of the β-endorphin measured from plasma is the pituitary. Therefore it is not
clear whether changes in this measure reflects changes in brain opioidergic function. The data
from effects of acute and chronic alcohol on enkephalins and dynorphins is limited. Both
decreases and increases of brain enkephalin levels after acute alcohol administration have been
found. In contrast, it seems that chronic alcohol administration more consistently produces
decreased met-enkephalin and dynorphin concentrations in several brain areas (Tabakoff et al.
1996).
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2.9. Strain and species differences in the behavioural effects of alcohol in rodents
Although moderate doses of alcohol consistently increase dopamine metabolism in the caudate
putamen and nucleus accumbens of rats and mice, marked species and strain differences have
been found in the behavioural effects of alcohol. Several mouse strains show locomotor
stimulation following administration of a relatively large dose of ethanol (> 2 g/kg, i.p.),
although sometimes after initial sedative phase (Frye and Breese 1981; Masur and Boerngen
1980; Phillips et al. 1995; Phillips et al. 1997). Ethanol-induced stimulation in mice appears to
depend on the dopaminergic system since in those strains in which ethanol induces the largest
increase of locomotor activity (DBA and BALB) it induces also the largest elevation of
dopamine metabolism (Kiianmaa and Tabakoff 1983; Tabakoff and Kiianmaa 1982).
Furthermore, as noted above alcohol-induced stimulation is attenuated by decreasing the brain
catecholamine content (Carlsson et al. 1972). In rats, small doses of ethanol (< 1.0 g/kg, i.p.),
have rarely induced stimulation (Carlsson et al. 1972; Waller et al. 1986), and usually no effects
on motor activity or performance have been seen (Frye and Breese 1981; Lewis and June 1990;
Päivärinta 1990). Large doses induce sedation and loss of the righting reflex.
2.10. Behavioural sensitization and dopamine
When an organism is exposed repeatedly to dependence-producing pharmacologically active
agents a common response to this is development of tolerance to a the drug effect. This
phenomenon can be interpreted to be due to the response of the organism in order to oppose the
effect of the drug and maintain the homeostatic state. However, in some situations, the opposite
phenomenon, sensitization of the response to a drug, is observed during and after repeated drug
administration.
2.10.1. Groups of drugs that induce sensitization
The groups of which are able to induce sensitization are summarized in Table 2.2.  and they
include psychostimulants, amphetamine and cocaine (Kalivas and Stewart 1991; Wise and Leeb
1993), µ-opioids (Ahtee and Attila 1987; Bartoletti et al. 1983; Kalivas and Stewart 1991),
nicotine (Johnson et al. 1995; Reid et al. 1996), NMDA-receptor antagonists (Wolf et al. 1993a;
Xu and Domino 1994), D2 dopamine receptor agonists (Hoffman and Wise 1992; Mattingly et al.
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1993; Traub et al. 1985; Wise and Carlezon 1994) and alcohol (Masur and Boerngen 1980;
Phillips et al. 1994; Phillips et al. 1997).
The most commonly studied drug responses showing sensitization are different forms of motor
activation, i.e. locomotor activity, stereotyped behaviour and rotational behaviour (Kalivas and
Stewart 1991; Robinson and Becker 1986; Wise and Leeb 1993). Behavioural sensitization was
first described for psychostimulants (Downs and Eddy 1932). Another widely studied group of
drugs in sensitization research are the µ-opioids of which morphine and methadone were the first
shown to have the ability to induce sensitization (Ahtee 1974; Babbini and Davis 1972;
Bartoletti et al. 1983). There is evidence from different behavioural models that sensitization is
really an opposite phenomenon to tolerance. For instance, in rats with unilateral 6-OHDA lesion
of the ascending dopamine pathways, the dose-response curve of the amphetamine-induced
circling behaviour has been shifted to the left (Badiani et al. 1997).
Table 2.2. Drugs of abuse (and some other compounds) that induce sensitization in
different behavioural models in experimental animals. Model indicates the parameter on
which the drug effect is increased following sensitization.
Drug Species Model Reference
Amphetamine rat locomotion (Robinson and Becker 1986)
rat rotation (Badiani et al. 1995b)
Cocaine rat locomotion (Karler et al. 1994)
rotation (Badiani et al. 1995b)
Morphine rat locomotion (Babbini and Davis 1972)
Methadone rat Stereotypies (Ahtee 1974)
Heroin rat locomotion (Marinelli et al. 1998)
Nicotine rat locomotion (Reid et al. 1996)
Alcohol mouse locomotion (Masur et al. 1986)
NMDA-receptor antagonists (e.g.
MK-801)
rat locomotion (Wolf et al. 1993a; Xu and
Domino 1994)
D2 dopamine- receptor agonists
(e.g. bromocriptine, quinpirole)
rat locomotion (Druhan et al. 1993; Hoffman
and Wise 1992)
Studies by Babbini and Davis (1972) and Kumar et al. (1971) demonstrated that when morphine
was given daily, over a wide dose range to rats, its locomotor activity increasing effect was
enhanced and tolerance developed to the initial sedative and cataleptic effects of the larger doses.
Although µ-opioids induce acutely very little stereotyped behaviour, after repeated and chronic
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treatment intense stereotypies emerge after subseqent acute treatment (Ahtee 1974; Cervo et al.
1981).
However, it is clear that although sensitization develops especially to some drug effects (motor
activity, reinforcement), tolerance can also develop to these same responses when the doses or
treatment schedule is different. For instance, when cocaine, amphetamine or opioids are
administered in continuous i.v. infusion, with subcutaneous pellets or in large doses with
frequent administrationd, tolerance emerges to the stimulant effects of the drugs as well (Stewart
and Badiani 1993). It has been also shown that when morphine is given at large doses over short
period, tolerance to the motor-stimulant effect develops, but when the same amount of the drug
is given in smaller doses and over longer period, then sensitization is observed (Stewart and
Badiani 1993). As a rule of thumb, it can be concluded that large doses and continuous
administration of the drug induce initial tolerance. However, also after a tolerance-inducing
treatment schedule, sensitization can develop after a long enough treatment-free withdrawal
period (Acquas and Di Chiara 1992; Ahtee and Attila 1987).
All of the sensitizing drugs and other treatments share an ability to induce motor stimulation
acutely, at least in certain conditions, and when given repeatedly, they induce sensitization.
However, the expression of the acute stimulatory effect of the drug is not a prerequisite for its
ability to induce behavioural sensitization. For instance, repeated local infusion of amphetamine
or a D1 dopamine receptor agonist SKF 38393 into the VTA induces sensitization to subsequent
systemic psychostimulant administration although these treatments do not induce acute motor
effects (Pierce et al. 1996b; Vezina 1996). In addition to the drugs, certain types of stressful
stimuli are able to sensitize experimental animals to subsequent stimulatory effects of the drugs
mentioned above (Deroche et al. 1995; Kalivas and Stewart 1991; Roberts et al. 1995; Shaham et
al. 1995).
2.10.2. The role of sensitization in the development of drug dependence
Although drugs which are capable of inducing behavioural sensitization (e.g. table 2.2) have
dissimilar behavioural actions especially in humans, like stress they are able to stimulate
dopaminergic transmission in brain (Abercombie et al. 1989; Kalivas and Duffy 1995; Kalivas
and Stewart 1991). Since dopamine, especially dopamine in the basal ganglia, is known to be
involved in the control of motor activity, it was proposed that this brain dopaminergic system
would be important also in sensitization (Ahtee 1974; Kalivas and Stewart 1991; Robinson and
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Becker 1986). The facts that repeated amphetamine may cause a psychosis very similar to
schizophrenia in humans and that dopamine receptor antagonists are effective antipsychotics,
also emphasized the importance of dopamine in sensitization. Indeed, amphetamine-induced
sensitization has been widely used as an experimental model of schizophrenia in laboratory
animals (Robinson and Becker 1986).
More recently, behavioural sensitization phenomenon has been linked to the development of
drug dependence and it has been intensively used as a tool in research of chronic behavioural and
neurochemical effects drugs of abuse (Ahtee and Attila 1987; Altman et al. 1996; Phillips 1997;
Robinson and Berridge 1993). It has been found that following repeated treatment with
sensitizing drugs, the reinforcing effects of these drugs are enhanced in experimental animals
(Lett 1989; Robinson and Berridge 1993; Shippenberg et al. 1996). For instance, smaller doses
of morphine are needed to induce conditioned placed preference in sensitized rats and the
sensitized animals discriminate the effects of smaller doses of the drug than the control animals
(Gaiardi et al. 1991; Gaiardi et al. 1986). Sensitized animals are more motivated to get i.v.
amphetamine and they learn i.v. drug self-administration quicker than naïve animals in an
operant paradigm (Piazza et al. 1989; Pierre and Vezina 1997).
In humans, the link between the development of drug dependence and sensitization has been
more difficult to demonstrate. The fact that repeated administration of amphetamine may induce
psychotic episodes very similar to schizophrenia suggest that dopaminergic systems may, indeed,
sensitize the individual to the effects of amphetamine. Short-term controlled clinical trials have
produced variable results showing either sensitization to behavioural effects of amphetamine
(Strakowski et al. 1996) or, more frequently, no change in amphetamine or cocaine effects
following repeated administration (Rothman et al. 1994; Wachtel and de Wit 1999). A study by
Bartlett et al. (1997) provided some evidence that cocaine-abusers who had developed paranoid
psychoses during repeated cocaine use (sensitized individuals) were also more vulnerable to
relapse following abstinence, suggesting that sensitization might play a role in the maintenance
of drug abuse.
Drug-induced sensitization is a long lasting phenomenon and may be linked to changes in
mechanisms regulating motivation and reinforcement. Since the brain mechanisms mediating
reinforcement are partially the same as those that are involved in sensitization, it is possible that
sensitization of these brain circuitries play an important role in drug craving and relapse
(Robinson and Berridge 1993).
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2.10.3. The role of conditioning in sensitization
In addition to the schedule of drug treatment and the doses used, another critical variable in
development of behavioural sensitization is the environment where the repeated treatment is
administered (Badiani et al. 1997; Hoffman and Wise 1992; Reid et al. 1996; Vezina et al. 1989).
It has been hypothesised that two different forms of sensitization exist and different neuronal
mechanisms may underlie these phenomena. Sensitization to µ-opioids and psychostimulants
develops rapidly and with relatively small doses when the drugs are administered repeatedly in
the same distinct environment (Babbini and Davis 1972; Badiani et al. 1997; Phillips et al. 1994;
Reid et al. 1996; Vezina and Stewart 1984). This form of sensitization is called context-
dependent sensitization. Thus, the most robust sensitization is seen when the experimental
animals are removed from their home cage to distinct experimental cage where the drug
treatment are given (Badiani et al. 1995a; Badiani et al. 1995b; Stewart and Vezina 1987; Vezina
and Stewart 1984). When the same dose of the sensitizing drug is given unsignalled (e.g. via i.v.
infusion) (Crombag et al. 1996) or injected in the home cage (Reid et al. 1996; Vezina et al.
1989; Vezina and Stewart 1984) sensitization to the subsequent drug challenge may not develop.
It is, therefore, clear that environmental cues linked to drug effects have an important role in the
expression of behavioural sensitization to acute drug effects (Robinson and Berridge 1993;
Stewart 1992; Stewart et al. 1984).
The importance and role of context-dependency of sensitization can be explained by the classical
Pavlovian conditioning associated with the drug effects (Stewart 1992; Stewart and Badiani
1993). According this idea, during a drug effect (unconditioned stimulus, UCS), normally neutral
environmental stimuli associated with the drug effect acquire the ability to cause similar or partly
similar activation of brain circuitries as the UCS, i.e. a neutral stimulus becomes a conditioned
stimulus (CS). The results of this process can be seen, e.g. sometimes animals in a drug-free state
show increased conditioned motor activity in the environment where they have been previously
treated with sensitizing stimulant (Neisenwander and Bardo 1987; Walter and Kuschinsky 1989).
However, this conditioned hyperactivity does not always occur and it is clear that it does not
alone explain the development of sensitization. Thus, for expression of context-dependent
sensitization, the interaction of UCS and CS are needed.
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2.10.4. Changes in dopamine release by repeated drug treatments
The initiation and expression of behavioural sensitization is thought to depend on the function of
ascending dopamine pathways. In the case of µ-opioids, the link between behavioural
sensitization and dopamine was revealed by studies showing that in rats withdrawn from chronic
methadone treatment, acute methadone induced a larger increase in the striatal HVA
concentration than in chronically saline-treated animals (Ahtee 1974). Since the methadone-
withdrawn animals showed also intense stereotypies, a behaviour which psychostimulant studies
have linked to striatal dopamine, it seemed evident that enhanced methadone-induced
dopaminergic activity was the reason for the increased activity of the animals. Subsequently it
has been shown that other µ-opioids share the same ability to induce sensitization of the
dopaminergic system (Attila and Ahtee 1984b; Kalivas 1985; Kalivas and Duffy 1987; Spanagel
et al. 1993).
In addition to stereotyped behaviour, the locomotor activity-increasing effects of morphine are
enhanced following repeated µ-opioid treatment. As discussed above, these behaviours are
thought to be mediated via separate dopaminergic pathways (Amalric and Koob 1993; Kelly et
al. 1975). Indeed, this was confirmed in studies showing that the effects of acute of morphine on
both mesolimbic and striatal dopamine turnover are sensitized in rats withdrawn long enough
from chronic morphine (Attila and Ahtee 1984b). Similarly, behavioural sensitization to the
psychostimulants, amphetamine and cocaine, has been shown to be associated with sensitization
of ascending dopamine pathways (Heidbreder et al. 1996; Kiyatkin 1994; Robinson et al. 1988).
2.10.5. Cellular changes in the dopaminergic cell body regions following repeated drug
treatment
Although there is much of evidence indicating that changes in presynaptic dopamine release are
important in the expression of behavioural sensitization to opioids and psychostimulants, it has
been shown that this effect is not important in the initiation of sensitization. This is indicated by
studies showing that although administration of amphetamine into the nucleus accumbens does
not induce sensitization to itself, to systemic amphetamine or morphine, it increases dopamine
release and the locomotor activity of the animals (Cador et al. 1995; Vezina 1993; Vezina and
Stewart 1990). However, when amphetamine is administered repeatedly into the VTA it induces
sensitization to both systemic amphetamine and morphine although intra-VTA administration
does not affect either the motor activity or accumbal dopamine release (Cador et al. 1995;
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Perugni and Vezina 1994; Vezina 1993). Similarly, administration of µ-agonists into the nucleus
accumbens induces acutely locomotor stimulation but not sensitization while intra-VTA µ-
agonists induce both stimulation and sensitization (Vezina et al. 1987). Furthermore, local
administration of naltrexone into the VTA but not into the nucleus accumbens prevents the
sensitization by systemic morphine (Kalivas and Duffy 1987).
However dopaminergic mechanisms are not without a role in the initiation of sensitization, since
the blockade of dopamine receptors during a sensitizing treatment can block the development of
sensitization (Kalivas and Stewart 1991). Critical dopamine receptors are located in the VTA as
indicated by the finding that blockade of D1 but not D2 receptors in this brain regions
antagonizes amphetamine-induced sensitization (Kalivas and Stewart 1991; Stewart and Vezina
1989; Vezina 1996; Vezina and Stewart 1989). Furthermore, repeated infusion of D1 dopamine
receptor agonists into the VTA induces long-lasting sensitization to the systemic administration
of amphetamine and cocaine (Pierce et al. 1996b). These findings have not been convincingly
repeated in studies with µ-opioids (Di Chiara 1995).
It has been suggested that a common factor in the initiation of behavioural sensitization by drugs
with different primary mechanisms of action is that they all increase somatodendritic dopamine
release (Kalivas and Stewart 1991) and, thus, activate D1 dopamine receptors in the cell body
regions. Activation of the D1 receptors, therefore, could lead to molecular changes in the neurons
in which they are expressed, which in turn, could lead to initiation of sensitization. Candidates
for these cells are GABAergic and glutamatergic neurons projecting to the dopaminergic neurons
(Kalivas et al. 1993). Although the importance of VTA dopamine receptors in the initiation is
supported by several reports, these findings have not been replicated by other groups (Jeziorski
and White 1995; Mattingly et al. 1994; Steketee 1998).
The role of glutamatergic mechanisms in the initiation of sensitization is supported by findings
showing blockade of NMDA and AMPA receptors can antagonize the behavioural sensitization
to amphetamine (Kalivas and Alesdatter 1993; Karler et al. 1991). However, there is evidence
that the non-competitive NMDA receptor antagonist, MK-801, can block morphine-induced
behavioural sensitization only at high doses (> 0.25 mg/kg) that together with morphine are
lethal (Vanderschuren et al. 1997). Furthermore, repeated administration of morphine increases
the expression of the GluR1 subunit of the AMPA receptors in the VTA, and the upregulation of
this subunit in the VTA by virally mediated gene transfer enhances the effect of the stimulatory
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effects of morphine in rats (Carlezon et al. 1997). Thus these findings suggest that AMPA but
not NMDA receptors are important in µ-opioid-induced sensitization.
A number of other alterations in the receptors, intracellular signalling systems, enzymes and cell
structure have been reported to occur in the VTA during and after chronic treatment with
psychostimulants, opioids and alcohol. One consistent finding is that early after discontinuation
of repeated cocaine treatment, the number of D2 dopamine autoreceptors and the efficacy of D2
agonists is decreased in the VTA (Kalivas and Stewart 1991; Wolf et al. 1993b). This might lead
to diminished autoregulation of dopaminergic neurons and enhanced efficacy of the stimulatory
afferents to increase the firing rate of dopaminergic neurons. This change is transient, however,
and not observed weeks after withdrawal although the sensitization may still be present.
Alterations in autoreceptor functions may, therefore, play a role only in the initiation of events
that lead to the development of sensitization (Wolf et al. 1993b).
Chronic treatment with morphine, cocaine and alcohol as well i.v. self-administration of heroin
increase levels of tyrosine hydroxylase and glial fibrillary acidic proteins, and decrease the
amount of neurofilament proteins in the VTA (Beitner-Johnson et al. 1992; Beitner-Johnson and
Nestler 1991; Bonci and Williams 1996; Ortiz et al. 1995; Self et al. 1995). The latter finding,
together with decrease of the size and number of dopaminergic neurons in the VTA (Beitner-
Johnson et al. 1992; Beitner-Johnson and Nestler 1993), suggest that some cell damage takes
place either during repeated drug exposure to drugs or withdrawal (Sklair Tavron et al. 1996).
Similar changes have not been observed in the SN.
2.10.6. Changes in postsynaptic mechanisms following repeated drug treatments
Even though there is evidence to support the involvement of presynaptic dopamine release as an
important mechanism in the expression of behavioural sensitization, there are also several
conflicting findings. Early after withdrawal from repeated cocaine or amphetamine treatment (<
5 days), behavioural sensitization is already present but the effect of an acute drug challenge on
dopamine release is not enhanced (Heidbreder et al. 1996; Segal and Kuczenski 1992; Wolf et al.
1993b). Sensitization of dopamine release apparently develops later, and is maximal about three
weeks after the end of the repeated treatment (Heidbreder et al. 1996; Wolf et al. 1993b). The
fact that D2 dopamine receptor agonists, i.e. drugs that decrease rather than increase presynaptic
dopamine release, also induce behavioural sensitization, indicates that dopamine-release
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independent mechanisms of sensitization must exist (Hoffman and Wise 1992; Rowlett et al.
1995; Szechtman et al. 1994).
Several intracellular molecular changes in both in the caudate-putamen and nucleus accumbens
have been found following repeated psychostimulant and µ-opioid treatments (Beitner-Johnson
et al. 1992; Hope et al. 1992; Miserendino and Nestler 1995). A consistent finding is that
expression of Gs protein and cAMP levels are elevated in the nucleus accumbens (Nestler et al.
1993; Terwilliger et al. 1991). Furthermore, the efficacy of D1 receptor agonists to elevate of
cAMP levels and to decrease the firing rate of the postsynaptic neurons is enhanced (Henry and
White 1991; Unterwald et al. 1996). Repeated administration of µ-agonists into the nucleus
accumbens sensitizes rats to the stimulant effect of systemically delivered amphetamine
supporting the involvement of accumbal, possibly postsynaptic mechanisms in the sensitization
(Cunningham et al. 1997). Changes in the functioning of accumbal excitatory amino acid
systems have been also suggested to play a role in the sensitization to psychostimulants
(Robinson et al. 1997). Pierce et al. (1996a) reported that only rats that expressed sensitization to
systemic cocaine were sensitized to intra-accumbens AMPA and showed increased glutamate
release following acute cocaine challenge.
2.11. Rodent lines differing in voluntary drug intake as models in research into drug-induced
locomotor stimulation and behavioural sensitization
Individuals within both animal and human populations differ substantially in their susceptibility
to develop alcoholism and other addictions. Research during recent decades has confirmed that
traits predisposing individuals to excessive and compulsive drug use are partially genetically
regulated (Crabbe et al. 1994; Pickens et al. 1996). Of the different forms of addiction,
experimental animals have been most widely used to study the genetic background of alcoholism
(Crabbe et al. 1994; Samson et al. 1988). Furthermore, twin and adoption studies have revealed
that a significant amount of the variability in human alcohol consumption can be explained by
genetic factors (Ball and Murray 1994; Cloninger 1987; Pickens et al. 1996).
Evidence about the role of heredity in addiction for other drugs among humans is not as well
understood as in the case for alcoholism, due to the paucity of studies carried out on this field
(Pickens et al. 1996). However, it is very likely that genetic factors also play an important role in
susceptibility to abuse of opioids and psychostimulants (Crabbe et al. 1994; Cunningham et al.
1992; Kosten et al. 1994; Shoaib et al. 1995).
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Since drug-induced psychomotor stimulation and sensitization are thought to be related to
reinforcement and development of addiction, differences in these responses have been sought in
rodent lines differing in their voluntary drug intake (Phillips 1997). As reviewed below, some
strain differences in these behavioural responses as well as in the sensitivity of the dopaminergic
systems to the stimulatory effects of drugs have been found.
2.11.1. Inbred rodent lines
C57BL/6 (C57) inbred mice were the first to show a relatively high preference for 10 % alcohol-
solution, while the DBA/2 (DBA) strain was found to avoid alcohol solution almost completely
(McClearn and Rodgers 1959). Contrary to the prediction by psychostimulant theory of
addiction, the DBA show greater locomotor stimulation as well as sensitization following acute
and repeated i.p. alcohol treatment than C57 mice (Cunningham et al. 1992; Phillips et al. 1994).
C57 mice consume also large amounts of aqueous solutions morphine and cocaine (Belknap
1990; Eriksson and Kiianmaa 1971; George et al. 1991a; Horowitz et al. 1977) indicating that, in
addition to alcohol, the reinforcing effects of other drugs of abuse are strong in C57 mice.
Interestingly, C57 are more stimulated by acute morphine than the DBA mice and they show
behavioural sensitization following repeated treatment, while the DBA mice do not
(Cunningham et al. 1992; Oliverio and Castellano 1974; Phillips et al. 1994; Reggiani et al.
1980). In line with these results, morphine elevates dopamine metabolism more in the striatum of
the C57 mice than in DBAs (Reggiani et al. 1980). The effects of acute amphetamine, cocaine
and other dopamine reuptake inhibitors on locomotor activity do not differ between the C57 and
DBA mice (Elmer et al. 1996; Phillips et al. 1994). There is evidence, however, that context-
dependent sensitization of locomotor activity following repeated amphetamine treatment is
greater in C57 mice than in DBA mice (Cabib 1993; Elmer et al. 1996; Tolliver and Carney
1994). These results may indicate that the C57 mice are more susceptible to conditioning effects
of cocaine than the DBA mice (Cabib 1993).
Another pair of inbred rodent lines, frequently used in drug dependence research consists of
Lewis and Fischer 344 rats. Lewis rats consume more aqueous solutions of alcohol (Suzuki et al.
1988), cocaine and morphine (George and Goldberg 1989) than the Fischer rats. In the
conditioned place preference (CPP) paradigm, the reinforcement induced by cocaine and
morphine is stronger in the animals of Lewis strain than in the Fischer strain (Beitner-Johnson et
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al. 1992; Kosten et al. 1994). Lewis rats also learn intravenous cocaine self-administration after
fewer training sessions and with lower doses than Fischer rats (Kosten et al. 1997). These
findings, therefore, suggest that the reinforcing effects of drugs of abuse from several classes are
strong in the Lewis strain, making these animals susceptible to drug intake.
Stimulatory effects of cocaine and amphetamine are larger in the Lewis rats than in the Fischer
rats (Camp et al. 1994; George et al. 1991b). Furthermore the Lewis strain is more susceptible to
the development of behavioural sensitization than the animals of the Fischer strain (Kosten et al.
1994). These line differences in behavioural responses to the psychostimulants may be due to the
larger amphetamine- and cocaine-induced increase of accumbal dopamine release in animals of
the Lewis strain than in those of the Fischer strain (Camp et al. 1994). However, there is some
evidence that these dissimilarities are at least partially due to differences in the bioavailability of
these drugs (Camp et al. 1994).
2.11.2. Rodent lines selectively bred for differential drug effects or preference
Following the original finding by the McClearn and Rodgers that inbred mice differ in voluntary
alcohol consumption (McClearn and Rodgers 1959), several rat strains for high or low voluntary
alcohol consumption have been produced with selective bi-directional breeding from
heterogenous strains. These kinds of strain pairs are effective tools in research into the biological
mechanisms involved in regulation of alcohol drinking behaviour since all differences between
the lines should be related to their differential alcohol intake and share at least partially the same
genetic background (Crabbe et al. 1990). It is assumed that the selective breeding segregates the
sets of genes contributing to the high and/or low drug-intake, and thus helps to identify
physiological and behavioural correlates of differential drug preference (Crabbe et al. 1994).
The project, which produced the alcohol-preferring AA (Alko, Alcohol) and alcohol avoiding
ANA (Alko, Non-Alcohol) rats was started by Kalervo Eriksson in the physiological laboratory
of the Finnish state alcohol monopoly, ALKO, in Helsinki. The first report about these rat lines
was published in 1968 (Eriksson 1968). Another breeding project was started already in the
1940´s in Chile, and it produced alcohol-preferring UChB and alcohol-avoiding UChA rats
(Mardones and Segovia Riquelme 1983). Subsequently, several other similar rat line pairs have
been produced, the most intensively studied being alcohol-preferring P and non-preferring NP
rats (Li et al. 1993) bred in the Indiana University School of Medicine, Indianapolis, USA. In
that institution, also another line pair has been produced, namely high-alcohol drinking HAD and
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low-alcohol drinking LAD rats (Li et al. 1993). Alcohol preferring SP (Sardinian Preferring) and
alcohol-avoiding SNP (Sardinian Non-Preferring) have been bred in the University of Cagliari in
Sardinia (Fadda et al. 1989).
2.11.2.1. Alko, Alcohol (AA) and Alko, Non-Alcohol (ANA) rats
Selection of the AAs and ANAs is based on the voluntary alcohol consumption under 24-h free
choice situation between 10 % alcohol solution (in water) and plain water. The alcohol drinking
behaviour of the AA and ANA rats has been described in several review articles (Eriksson and
Rusi 1981; Hilakivi et al. 1984; Sinclair et al. 1989). For instance, alcohol consumption of male
AA rats from generations F61-F77 has varied between 5 –7 g/kg of absolute ethanol/day, while the
ANA rats consume less than 1 g/kg (Maija Sarviharju, personal communication). The level of
alcohol drinking of the AA rats is comparable to that of other alcohol-preferring rat lines
(McBride and Li 1998) (see below). The AA rats also learn to work for alcohol in an operant
chamber without any previous alcohol experience (Hyytia and Sinclair 1989).
Several both behavioural and physiological differences as well differences in response to alcohol
and other drugs and environmental stimuli (e.g. stress) have been found between the AA and
ANA rats (Sinclair et al. 1989).  With respect to possible roles of anxiety and stress in the
etiology of alcoholism and drug dependence in general, it has been of great interest to explore
different anxiety measures and responses to stressful situations in the AA and ANA rats. One
could speculate that that the AA rats would drink alcohol in order to relieve anxiety. On the other
hand, the AA rats could be sensitive to stress, a trait which could contribute to the sensitization
of the brain mechanisms involved in drug reinforcement (see above).
However, in the tests for level of anxiety, such as elevated plus maze or conflict tests, either no
differences between the strains have been found (Tuominen et al. 1990; Viglinskaya et al. 1995)
or the ANA rats have shown greater anxiety than the AA rats (Knapp et al. 1997; Moller et al.
1997). Furthermore, the ANA rats show greater or faster response to different aversive stimuli,
such as shock-prod in defensive burying paradigm (Sandbak et al. 1998), forced swimming test
(Korpi et al. 1988; Sandbak et al. 1998) and less habituation to aversive stimuli during testing of
nociception (Honkanen et al. 1995). These traits may play a role in the low alcohol drinking of
the ANA rats and their lack of habituation to aversive properties of alcohol solution.
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Also metabolic factors seem to be important in the differential alcohol drinking of AA and ANA
rats. Following alcohol challenge, acetaldehyde accumulates in the blood of ANA rats probably
causing aversion to alcohol (Eriksson 1973). The importance of the ethanol metabolism as the
limiting factor of alcohol drinking by the ANAs is also suggested by the finding that AA rats do
not develop alcohol preference when they are transplanted with livers from ANA rats (Eriksson
et al. 1997). The ANA rats are also more sensitive to strong or aversive tastes, since they
generally drink less of the bitter, salty, and sour solutions than the AAs or Wistars (Sinclair et al.
1992b). This finding suggests that the taste is an important factor in limiting the alcohol drinking
of the ANA rats. However there is strong evidence for a post gustatory mechanism for
differential alcohol drinking of these rats since i.v. alcohol maintains operant responding in the
AAs but not in the ANAs (Hyytiä et al. 1996).
It was many years ago found that concentrations of the dopamine and 5-HT differed in the brains
of AA and ANA rats, levels of both neurotransmitters being higher in the AA rats than in the
ANA rats (Ahtee et al. 1980; Ahtee and Eriksson 1972; Ahtee and Eriksson 1975).
Concentrations of the 5-HT metabolite, 5-HIAA, were also higher in the brains of the AA rats
(Ahtee and Eriksson 1972; Korpi et al. 1988). The activities of tyrosine hydroxylase and dopa
decarboxylase are markedly higher in the brains of AA rats than ANAs (Pispa et al. 1986). This
difference may, at least partly, underly the greater concentrations of dopamine in the AAs than
ANAs. However, no differences were found in the activities of dopamine-β-hydroxylase, MAO
or COMT between the rat lines.
Dopamine-related behaviors have not been extensively studied in the AA and ANA rats. An
acute intraperitoneal dose of  alcohol (1 g/kg or lower) does not alter the locomotor activity of
these animals, but the AA rats show significant stimulation after an alcohol drinking bout in a
limited access paradigm (Päivärinta and Korpi 1993). This finding suggests that voluntary
alcohol drinking activates dopaminergic mechanisms in the brains of AA rats. Intraperitoneal
alcohol elevates extracellular dopamine levels in the nucleus accumbens of freely moving AA
and ANA rats, but there is no difference in this response between the rat lines (Kiianmaa et al.
1995).
Given the possibility that alcohol can mediate its reinforcing effects via endogenous opioids, it is
interesting that several differences in the brain opioid systems of the AA and ANA rats have
been found. For instance β-endorphin-like immunoreactivity (β-EPLIR) is higher in the septum
and lower in the amygdala and periaqueductal gray matter of the AA rats than ANA rats.
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However, there is no significant difference in the concentration of β-EPLIR in the nucleus
accumbens, caudate-putamen or hypothalamus between the strains (Gianoulakis et al. 1992).
Spontaneous release of β-EPLIR is larger in the ANA rats than in the AAs, but there is no
difference in the alcohol-induced release between these strains (de Waele et al. 1994).
Interestingly, most of the β-endorphin-like peptides released from the hypothalamus of the ANA
rats were of acetylated forms that are devoid of opioid activity (de Waele et al. 1994). This may
indicate a deficit of the reward system in the ANA rats that may contribute to their reduced level
alcohol consumption.
Furthermore, basal levels of (Met)enkephalinArg6Phe7, a marker of the proenkephalin system
and levels of dynorphin A and dynorphin B, were are lower in the nucleus accumbens of the AA
rats than ANA rats. The levels of (Leu)enkephalinArg6, another marker of the dynorphin system
were also lower in the VTA of the AA rats than in ANAs. These results suggest that opioidergic
regulation of mesolimbic the dopamine system differs in the AA and ANA rats.
de Waele et al. (1995) reported that δ- and µ- opioid receptor densities are both markdly lower in
the ANA rats than AAs in several brain areas, including caudate-putamen (µ and δ) and VTA
(µ). However, these results have not been replicated by others either with agonist (Soini et al.
1998) or antagonist (Soini et al. 1999) autoradiography. The reasons for these discrepancies are
not clear. However, given the large within strain variability in these measures in the AAs and
ANAs, one of the problems with the study by de Waele et al. is that most of the data was derived
only from three animals/strain. There are inconsistencies also in the data from studies with
agonist and antagonist binding (Soini et al. 1999; Soini et al. 1998), but one replicated result is
that µ-receptor density is higher in the SNr of the AA rats than ANAs.
The AA rats consume more aqueous solutions of cocaine and etonitazene, a µ-opioid receptor
agonist, than ANA rats or non-selected Wistar rats (Hyytiä and Sinclair 1993). Thus, the
reinforcing effects of opioids may be stronger in the AA rats than in the ANA rats. Hence, the
brain reward mechanisms of the AA rats may be also highly sensitive to activating stimuli other
than alcohol. Together these data indicate that there are genetically regulated differences in the
brain opioid systems between the AA and ANA rats and these traits may contribute to their
differential alcohol preference
In conclusion, there are several physiological and behavioural differencies between the AA and
ANA rats that may contribute to the differential alcohol preference of these animals. However,
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initial reason for the development of high alcohol preference and its maintenence in the AA rats
is not known.
Table 2.3. Summary of major neurobiological and behavioural differences between the AA
and ANA rats
Dopamine content AA > ANA
5-HT content AA > ANA
Tyrosine hydroxylase activity AA > ANA
β-endorphin content AA > ANA (Septum), AA < ANA (PAG, Amygdala)
Enkephalin content AA < ANA (Acb, VTA)
Dynorphin content AA < ANA (VTA)
µ-receptor density AA > ANA (SNr)
Etonitazene/Cocaine drinking AA > ANA
Anxiety AA < ANA
Emotionility AA < ANA
Acb = nucleus accumbens, PAG = periaqueductal gray matter, SNr = substantia nigra pars
reticulata, VTA = ventral tegmental area
2.11.2.2. P/NP, HAD/LAD and SP/SNP rats
The findings from several high or low alcohol-drinking rat strains have been recently reviewed
(McBride and Li 1998) so these other strain pairs are only briefly dealt with here.  In comparison
with AA and ANA rats, different results have been obtained from studies with other rat lines
pairs, i.e. both 5-HT and 5-HIAA concentration are lower in the brains of alcohol-preferring P
and HAD rats than in their alcohol-avoiding counterparts (Gongwer et al. 1989; Murphy et al.
1982). Similarly, while no differences have been found in the levels of 5-HT receptors in the
brains of AA and ANA rats (Ciccocioppo et al. 1997; Ciccocioppo et al. 1998; Korpi et al.
1992), the P rats have lower concentrations of 5HT2A and 5-HT3 receptors in some brain regions.
Concentrations of both dopamine and DOPAC are lower in the nucleus accumbens and dorsal
striatum of the P and HAD rats than in the NP and LAD rats (Gongwer et al. 1989; McBride et
al. 1995; Murphy et al. 1987). In the brains of the Sardinian rats, the levels dopamine and its
metabolites do not differ (Fadda et al. 1990). However, the density of D2 dopamine receptors is
lower in the striatum of the SP than in SNP rats, and this result has been replicated with P and
NP rats (McBride et al. 1993; Stefanini et al. 1992). However, very small differences have been
found in the D2 receptor binding or mRNA levels between the AA and ANA rats (Korpi et al.
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1987; Syvalahti et al. 1994). In summary, these results suggest that compromised dopaminergic
and 5-HTergic transmission may contribute to the high alcohol consumption of the P, SP and
HAD rats but different mechanisms underlie the alcohol-preference of the AA rats.
No differences in the response of dopaminergic system to alcohol have been found in the case of
HAD/LAD lines of rats (Yoshimoto et al. 1992). However, in the alcohol-preferring SP rats, i.p.
alcohol induces a greater elevation of DOPAC and HVA concentrations in the several brain
areas than in the SNP rats (Fadda et al. 1990). Small doses of i.p alcohol have been reported to
increase locomotor activity of the P rats but not that of nP rats, but during 5-day repeated
treatment the responses to alcohol did not change in either strain (Waller et al. 1986). However,
in a work by Criswell et al. (1994) neither P nor nP rats were stimulated by alcohol. Weiss et al.
(1993) provided evidence suggesting that the accumbal dopamine system in the P rats might be
very sensitive to the activating effect of voluntary alcohol drinking.
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3. AIMS OF THE STUDY
The aim of this series of studies was to explore the role of dopaminergic mechanisms and their
susceptibility to sensitization as predisposing factors to alcohol- and drugs addiction. Selectively
outbred alcohol-preferring AA and alcohol-avoiding ANA rats were used as models of
individuals susceptible and non-susceptible to substance abuse, respectively.
Specific goals of this work were
1. to validate the utilization of 3-MT measurements for the assessment of brain dopaminergic
function
2. to examine whether alcohol modulates brain dopaminergic neurons differentially in the
brains of the AA and ANA rats by assessing 3-MT levels
3. to examine whether alcohol- cocaine- or morphine-induced dopamine-dependent behavioural
responses (motor activity) differ between the AA and ANA rats
4. to explore whether the brain dopamine mechanisms are differentially modulated by µ-opioids
(morphine) in the AA and ANA rats
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4. MATERIALS AND METHODS
4.1. Animals
All animal experiments were approved by the local institutional animals care and use committee
and conducted according to the “European Convention for the Protection of Vertebrate Animals
used for Experimental and other Scientific Purposes”.
Three-months-old Wistar rats used were obtained either from the animal facilities of Department
of Pharmacy, Faculty of Science, University of Helsinki (unpublished experiments, III) or from
the Department of Laboratory Animals, University of Helsinki (IV). Three- to four-months-old
alcohol-preferring AA and alcohol-avoiding ANA rats from generations F61 and F62 (I), F68-F70
and F73 (III, IV) and F69 and F72 (IV) were obtained from Biomedical Research Center of Alko
Ltd (now: Department of Alcohol Research and Mental Health, National Public Health Institute,
Helsinki). The animals were maintained in individual stainless steel wire mesh cages (II) or in
groups of four to five animals (I). The AA and ANA rats used in the works III and IV were
maintained in Macrolon VI cages in groups of 4-5 per cage.  12/12-h light/dark cycle (lights on
at 6:00 a.m.), temperature of 22 ± 2 °C and relative humidity of 50 ± 5% were maintained in the
colony and experimental rooms.
Experiments were conducted in the Division of Pharmacology and Toxicology (IV), where the
rats were given Altromin 1324 rodent food (Chr. Petersen A/S, Denmark) or in the Alcohol
Research Center, where the animals were given R3 pellet food (Ewos AB, Södertälje, Sweden)
or powdered rodent food (II, Ewos R3). Tap water was available ad libitum except as noted in
the description of experiments. The rats were accustomed to handling at least for 3 days before
the start of the experiments.
4.2. Focused microwave irradiation and brain dissection (I, II, III, V)
In most of the experiments exploring neurochemistry, the rats were killed by high intensity
microwave irradiation focused to the head using NJE 2603-10 kW microwave irradiator (New
Japan Radio Inc., Japan) set at 7 kW and 1.4 s. Brains were removed from the skull and placed in
a stainless steel brain mould (designed by Esa Korpi, I, II) or zinc mould (RBM-4000C, ASI
Instruments, USA, III, VI). Brains were sectioned coronally with preadjusted steel wires (in self-
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constructed mould) or razor blades (in RBM-4000C) at 2.7, - 0.3 and -4.6 mm from bregma (fig
4.1.).
Figure 4.1. Description of the brain dissection. The lines in the figure illustrate the sites where
the brain was sectioned into coronal slices. Different structures to be studied were dissected from
these slices. PFC = prefrontal cortex, CPu = caudate-putamen, Acb = nucleus accumbens, Hy =
hypothalamus, A = amygdala.
In the dissection of the prefrontal cortex (Fig. 4.1.), the area ventral to the rhinal fissure was
discarded from the first rostral slice and then vertical cuts, 1 mm from the midline, were made on
both sides of the remaining dorsal piece; the medial section was saved as the prefrontal cortex.
The dorsal striatum (caudate-putamen about 20 mg wet weight), nucleus accumbens (10 mg)
were dissected from the second rostral slice using needles with inner diameters of 3.0 and 2.0
mm, respectively, and the brain area located ventrally to the nucleus accumbens was also
dissected and saved as the olfactory tubercle (15 mg). The amygdala (60 mg) and hypothalamus
were dissected from the third slice by cutting along their upper and lateral borders. In some
experiments the nucleus accumbens, olfactory tubercle and amygdala were combined and this
sample was called the “limbic forebrain”. Tissues were stored at -80° C until dopamine and its
metabolites were assayed.
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4.3. Measurement of dopamine metabolites from brain samples (I, II, III, V)
Monoamines and their metabolites were determined with HPLC with electrochemical detection.
In these analyses, tissues were homogenised in 1000 µl of 0.2 M HClO4, and 25 µl
KOH/HCOOH buffer was added to the homogenates to adjust pH to 2.4. Samples were
centrifuged at 5500 x g for 45 min and in some experiments after that at 28,000 x g for 20 min.
The supernatants were purified using the method described earlier (Haikala 1987). In brief, a
950-µl sample of supernatant was pipetted onto Sephadex G-10 columns and washed with 1.8 ml
of 0.01 M HCl. Dopamine and 3-MT were collected with 1.7 ml of 0.01 M HCl and 1.0 ml of
0.02 M NH3. The acidic metabolites, HVA and DOPAC, were collected by washing the columns
with 1.0 ml of 0.02 M NH3 and 1.0 ml of 0.01 M KOH. Twenty µl of 2.6 mM sodium
pyrosulfite and 5.7 mM ascorbic acid was added to the tubes containing dopamine/3-MT and
DOPAC/HVA, respectively. The samples were assayed for the concentration of dopamine and
its acidic metabolites using HPLC with electrochemical detection as described by Piepponen et
al. (1999).
3-MT concentrations in the samples were measured using an ESA Coulochem electrochemical
detector equipped with model 5021 conditioning cell and 5014 high sensitivity analytical cell
after HPLC separation. The conditioning cell was set at + 0.02 V and detectors 1 and 2 were set
at + 0.20 V and + 0.38 V, respectively. The HPLC system consisted of a Pharmacia LKB model
2248, CMA/200 autoinjector with 200 µl sample loop (CMA/Microdialysis, Stockholm,
Sweden), SSI pulse dampener model 20-0225 (Scientific Systems Inc., State College, PA, USA)
and Spherisorb ODS 5 or 10 µ, 25 cm column. The mobile phase used in the 3-MT
determination contained 10 mM NaH2PO4, 1.2 mM octanesulphonic acid, 4.5 mM di-
butylamine, 10 % methanol (v/v) and adjusted to pH 2.7 with phosphoric acid.   The flow rate of
the mobile phase was 1.0 ml/min. The column temperature was kept at 45°C with a Bio-Rad
column heater. All reagents used in the HPLC assays were p.a. grade and purchased from E.
Merck (Darmstadt, Germany) except dibutylamine (DBH Ltd., Poole, England) and
octanesulphonic acid (Fluka, Buchs, Switzerland).
In work II, the dopamine metabolites were analysed by mass spectrometry as described
elsewhere (Karoum and Egan 1992). These samples were analysed in NIMH Neuroscience
Center in Washington, DC, since the method for analysis of small 3-MT concentrations was not
available in Department of Pharmacy. After dissection the tissues were homogenised in 500 µl of
1M HCl containing deuterated 3-MT, DOPAC and HVA that were used as internal standards.
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Homogenates were centrifuged and supernatants stored at -80 °C until sent in dry ice from
Helsinki to Washington, DC. Protein contents of the samples were assayed by a modification of
the method by Lowry et al. (Peterson 1977).
4.4. Measurement of striatal COMT activity
Analysis of COMT activity from the striata in vitro was performed as described earlier (Reenilä
et al. 1995). Briefly, rat striata were homogenised in 10 mM phosphate buffer containing 0.5 mM
dithiothretiol. The homogenates were centrifuged 900 x g for 10 min and the COMT activity was
measured from the supernatants as duplicates with 240 mM dihydroxybenzoic acid. The reaction
products were quantified by HPLC with electrochemical detection.
Inactivation of enzymes involved in dopamine metabolism by microwave irradiation was
assessed also by examining whether changes in concentrations of dopamine or its metabolites
took place in microwave-irradiated tissues after death. Eleven rats were killed with head-focused
microwave and striata dissected. Either left or right striatum was frozen immediately after
dissection on dry ice, with the contralateral side being left on moistured filter paper on a petri
dish at room temperature for 30 min after which they were frozen on dry ice. Tissues were stored
at -80 °C until metabolites of dopamine were assayed.
4.5. Measurement of plasma alcohol and morphine concentrations (II, III, IV)
Trunk blood samples were centrifuged, and serum was separated and stored at 20 °C until
assayed for ethanol content by headspace gas chromatography (Eriksson et al. 1978). Morphine
and its metabolites, morphine 3-glucuronide and morphine 6-glucuronide, in rat plasma and
brain were determined in Pharmacological and Toxicological Laboratory of the National Public
Health Institute. The HPLC (HP 1081 B, Hewlett-Packard, USA; 4.6 mm x 25 cm Zorbax ODS
C18 Column, Du Pont, France) method described earlier (Svensson 1986; Svensson et al. 1982)
utilised both electrochemical and UV (PU 4020, Pay Unicam, England) detection in the same
run. Before the analysis brains were homogenised mechanically (Ultra Turrax, Janke & Kunkel,
Germany) in 0.1 M HClO4 (Merck, Germany). Oxymorphone was used as an internal standard.
Extraction and other details are described in the original papers (Svensson 1986; Svensson et al.
1982).
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4.6. Voluntary alcohol drinking in a limited access paradigm (III)
The experiment was started by tranferring the animals were to individual cages, where they
underwent forced alcohol drinking for one week, 10% ethanol (by volume) in tap water being the
only fluid available. During the next three weeks both water and alcohol were available, after
which the access to alcohol was restricted first to 4 h/day three times a week, i.e. on every
second working day and then the availability of alcohol was gradually restricted to 20 min/day
three times a week.
4.7. Measurement of motor activity (IV)
The horizontal locomotor activity of the animals was registered daily in transparent Macrolon
cages by means of computer controlled photocells. Test cages were placed on top of a sensor
(area: 18 x 33 cm) containing 40 photocells under a transparent cover. Interruptions of light
beams to the photocells during horizontal movement of the animals were registered with
computer.
In some cocaine experiments the behaviour of the rats was also videotaped at 5-min intervals for
10 s during 60 min after the treatments. From these recordings, behaviour of the animals was
later rated using a modified scale described by Ellinwood and Balster (1974). On this scale, 1 =
asleep; 2 = inactive; 3 = normal in place activity; 4 = normal, alert, active; 5 = hyperactive; 6 =
slow patterned stereotyped behaviour; 7 = fast patterned stereotyped behaviour; 8 = restricted
stereotyped behaviour.
4.8. Drugs
Alcohol (ethanol)-solutions were prepared from 96 % ethanol (Alko Ltd.). Alcohol was given
i.p. as a 12 % (m/V) solution prepared in 0.9 % NaCl, and in the alcohol-drinking experiments,
alcohol was given as a 10 % (V/V) solution prepared in tap water. Pargyline was purchased from
Research Biochemicals Inc. (Natick, MA, USA) and was given i.p. (1 ml/kg in 0.9 % NaCl).
Cocaine HCl (Ph. Eur) and morphine HCl (Ph. Eur) were purchased from University Pharmacy,
Helsinki and were given as base (1 ml/kg in 0.9 % NaCl), i.p. and s.c., respectively. Haloperidol
solution (0.5 mg/ml in 0.9 % NaCl) was prepared from Serenase® 5 mg/ml (Orion Pharma,
Espoo, Finland) and was given i.p.
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4.9. Treatments
4.9.1. Determination of 3-MT levels in rats killed by decapitation or head-focused microwave
irradiation after morphine and haloperidol
Rats were treated with morphine at doses of 1, 3 or 15 mg/kg or haloperidol at the dose of 0.5
mg/kg. Control animals received an equivalent volume of saline. The morphine doses were
chosen on the bases of their different behavioural effects in rats. The lowest dose used produces
immediate locomotor stimulation without initial sedation phase and the highest dose produces
maximal catalepsy in rats (Babbini and Davis 1972). The haloperidol dose used was relatively
high and it was chosen, since it has been found to decrease 3-MT levels (Waldmeier et al. 1981).
Sixty min after the injection the rats were either decapitated or killed by head-focused
microwave irradiation as described above.
When the rats were killed by decapitation, their brains were removed from the skull within 30-40
s from decapitation and rinsed immediately in ice-cold saline. The time between sacrifice and
freezing of tissues did not exceed 3 min. The rats killed by microwaves were decapitated and the
heads were allowed to cool in crushed ice for 1 min before the brains were removed from the
skulls. The dissection was carried out within 5 min after irradiation.
4.9.2. Chronic morphine treatment and acute morphine challenge (I)
Rats were given morphine or saline twice daily at 08.00 and at 18.00 as follows: 10 mg/kg on
days 1 and 2, 15 mg/kg on days 3 and 4 and 20 mg/kg from day 5 to 20. After the last injection
on the morning of the 20th day, the rats were removed to the experimental room. After a 48-h
withdrawal period, half of the animals in both groups received a challenge dose of morphine (10
mg/kg) and the rest were given saline. Sixty min after the injection the rats were sacrificed by
high intensity microwave irradiation
4.9.3. Determination of dopamine metabolism in the AA and ANA rats after intraperitoneal
alcohol (II)
In the first experiment, the AA and ANA rats received alcohol at a dose of 1 g/kg, i.p. or an
equivalent volume of saline. In the second experiment, the AA, ANA and Wistar rats were first
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given alcohol (1 g/kg) or an equivalent volume of saline as above. Ten min after the first
injection, all rats received another i.p. injection containing the MAO inhibitor pargyline at a dose
of 75 mg/kg to inhibit monoamine oxidase. Twenty min after the alcohol injection, each rat was
taken from its cage to another room and killed immediately by microwave irradiation focused to
the head. Trunk blood samples were collected into pre-chilled test tubes for the determination of
ethanol levels and brains were dissected and stored frozen for monoamine determination.
4.9.4. Determination of brain dopamine metabolism in AA rats after voluntary intake of
alcohol or water (III)
Following the establishment of alcohol drinking in the limited access paradigm, the rats were
divided into three groups matched for their level of alcohol drinking during the three preceding
sessions. The animals of the control group were weighed and immediately killed with head-
focused microwave irradiation. The animals in the second group were given access to alcohol as
usual and then killed 20 min later. The animals in the third group were given access to a tube
containing water instead of alcohol and killed 20 min later.
4.9.5. Determination of locomotor activity of the rats after acute and repeated alcohol, cocaine
or morphine (IV)
On the first experimental day, all rats were given saline (i.p.), and thereafter they were treated
with alcohol (ethanol, 0.4 or 1.0 g/kg) on six consecutive days, or cocaine (5 or 20 mg/kg, i.p.)
on four consecutive days. Following repeated alcohol-, cocaine- or vehicle-treatments, on the
eighth (alcohol experiment) or on the sixth (cocaine experiment) day, all rats were given again
saline. The control animals were given daily an equivalent volume of saline (i.p.). The locomotor
activity was measured daily for 30 (alcohol) or 60 min (cocaine) following the saline or drug
injections. The 0.4 g/kg dose of alcohol was anticipated to induce BACs near to those that the
AA rats achieve during voluntary alcohol drinking (≈ 10 mM) and the larger dose has been used
previously in the neurochemical experiments. The selection of cocaine doses was based on the
literature showing that 20 mg/kg consistently induces sensitization (e.g Chen et al. 1996;
Heidbreder et al. 1996; Reimer and Martin-Iverson 1994), while the 5 mg/kg dose, according to
some reports, does not (Reimer and Martin-Iverson 1994).
Since there were no rat line differences in the effects of saline injections on motor activity, and
because the response to saline did not change in any rat line during repeated treatment, no
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separate control groups were included in further experiments. In these experiments, all rats were
treated with saline on the first experimental day and from day two to five, the rats were treated
with morphine (0.3, 1.0 and 3.0 mg/kg, s.c.) or cocaine (10 mg/kg). On the sixth experimental
day, all animals were again given saline injections. The rationale underlying the selection of
morphine doses was that they would increase dopamine release and motor activity without
provoking a long lasting sedative phase (Babbini and Davis 1972; Di Chiara and Imperato
1988b). Since the doses used were rather small, unlike those used in work I, the effects of
challenge doses were not studied following the withdrawal period (Ahtee and Attila 1987). An
additional cocaine dose (10 mg/kg) was tested because no sensitization to the locomotor
stimulant effect of cocaine was found with the doses 5 or 20 mg/kg.
4.9.6. Determination of dopamine and serotonin metabolism in the rats after acute morphine
(V)
In Experiment 1, the animals were given saline or morphine hydrochloride at the doses of 1 or 3
mg/kg, except that the Wistar rats were given the 3 mg/kg dose only. The animals were killed 60
min after injections with head-focused microwave irradiation. In Experiment 2, only AA and
ANA rats were used, and they were given saline or morphine at the dose of 1 mg/kg and killed
120 min later.
4.9.7. Statistics
In work I, the effects of acute and chronic treatments and the interaction between them were
analysed with 2-way analysis of variance (2-way ANOVA) followed by Tukey compromise
post-hoc test. In work III, the effects of drinking on the concentrations of dopamine metabolites
were statistically evaluated using one-way ANOVA followed by Tukey compromise test when
appropriate. In the experiments with different rat lines, drug effects, rat line differences and
interaction between rat line and drug effect being evaluated first we used 2-way ANOVA
followed by the Student’s t-test (II) or the Tukey compromise test (V). Differences in the basal
concentrations of monoamines and their metabolites between the rat lines were tested with
Student’s t-test with Bonferroni adjustment (V).  The locomotion data were statistically
evaluated by ANOVA for repeated measures (IV). When appropriate, comparisons between
groups or sessions were conducted using contrast analysis with Bonferroni adjustment or Tukey
compromise test (when a separate control group was included). The behavioral rating scores
were analyzed with Kruskall-Wallis statistics, after which comparisons between groups or
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sessions were performed with Mann-Whitney U-test. Two-way ANOVA was used to test
significance of differences in the plasma morphine concentrations (IV)
5. RESULTS
5.1. Effects of acute morphine and haloperidol and chronic morphine on brain 3-MT levels (I
and unpublished results)
The concentrations of 3-MT in brain of rats killed by decapitation without microwave irradiation
were about 10-fold higher than those of rats killed by microwaves (Table 5.1.). The basal
concentrations of dopamine and its acidic metabolites (DOPAC and HVA) differed only slightly
between the microwave-irradiated and non-irradiated brains.
Table 5.1. Concentrations of dopamine metabolites 3-methoxytyramine (3-MT), 3,4-
dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the dorsal striatum
and limbic forebrain (including the nucleus accumbens, olfactory tubercle and amygdala)
of the rats killed either by decapitation or brain-focused microwave irradiation.
Microwave-killed rats Decapitated rats
STRIATUM ng/g (n) ng/g (n)
3-MT 19.8 ± 1.2 13 210 ± 20 6
DOPAC 1166 ± 74 13 1357 ± 73 6
HVA 682 ± 50 13 802 ± 50 6
LIMBIC FOREBRAIN
3-MT 3.3 ± 0.3 13 25.3 ± 2.5 6
DOPAC 327 ± 16 13 284 ± 11 6
HVA 166 ± 7 13 156 ± 9 6
The results are given as mean ± S.E.M.
Concentrations of dopamine in the striata frozen immediately after dissection did not differ from
concentrations in the striata left at room temperature for 30 min suggesting that no significant
post-mortem dopamine metabolism occurred in samples after microwave irradiation (Table 5.2.).
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Table 5.2. Concentrations of dopamine and its metabolites 3-MT, DOPAC and HVA in
microwave-killed rat striata frozen immediately after killing in dry ice (0 min) or in striata
left at room temperature (22 °C) for 30 min before freezing.
Concentration (ng/g) in samples frozen at
0 min 30 min
DOPAMINE 15570 ± 700 15570 ± 620
3-MT 19.2 ± 0.7 20.3 ± 0.8
DOPAC 1270 ± 60 1260 ± 75
HVA 750 ± 30 720 ± 55
The results are given as mean ± S.E.M.
COMT activity was reduced by 86 % (P<0.01, Student’s t-test, n=5) in the striata of rats killed
by microwave irradiation (3.20 ± 0.38 pmol/mg protein, mean ± S.E.M) as compared to
decapitated rats (22.8 ± 0.76 pmol/mg protein, mean ± S.E.M). Small morphine doses did not
affect 3-MT levels in decapitated rats, but elevated those by 30 - 50 % in microwave-killed rats
(Fig 5.1.). Furthermore, increased 3-MT levels were found after a high dose of morphine (15
mg/kg) in microwave-irradiated brains, while this dose significantly decreased 3-MT
concentrations in brains of decapitated rats in comparison with saline treated controls.
Fig. 5.1. Effects of different doses of morphine (mo, mg/kg) on the concentrations of 3-
methoxytyramine (3-MT) in the striatum and limbic forebrain of rats killed by head-
focused microwave irradiation or decapitation. Basal 3-MT concentrations: microwave
group; striatum 20.6 ± 0.9, limbic forebrain 3.3 ± 0.2; decapitated group; 210.2 ± 19.6, limbic
forebrain 38.0 ± 3.8 (ng/g tissue, mean ± S.E.M., n = 6-8). * P < 0.05 and ** P < 0.01 in
comparison with corresponding control group (Tukey compromise post-hoc test).
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Similarly, haloperidol increased 3-MT concentrations in the brains of rats killed by microwave
irradiation while it tended to decrease 3-MT in decapitated rats (Fig. 5.2.). There were only small
quantitative differences in the effects of drug treatments on DOPAC and HVA concentrations
(data not shown)
Figure  5.2. Effects of haloperidol (0.5 mg/kg) on the concentrations of 3-methoxytyramine
(3-MT) of the rats killed by microwave irradiation by decapitation. Basal 3-MT
concentrations: microwave group; striatum 19.8 ± 1.7, limbic forebrain 3.1 ± 0.3; decapitated
group; striatum 192.7 ± 14.8, limbic forebrain 42.5 ± 3.2 ng/g tissue (mean ± S.E.M., n = 6-8).
Forty-eight hours after withdrawal from 20-day morphine treatment, neither the basal
concentrations of dopamine nor any of its metabolites differed between the morphine- or saline-
treated groups of rats killed by microwave irradiation (I). Acute morphine treatment after a 48-h
withdrawal increased concentrations of all dopamine metabolites measured (I). The elevation of
3-MT by morphine was significantly larger in both caudate-putamen and limbic forebrain of rats
withdrawn morphine than in those of animals treated chronically with saline. In the caudate-
putamen, the effect of morphine on HVA but not on DOPAC was also sensitized in the
morphine-withdrawn rats. No such sensitization was observed in the limbic forebrain of the
chronically saline- or morphine-treated animals.
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5.2. Effects of intraperitoneal alcohol on dopamine release and metabolism in the brains of
AA and ANA rats (II)
In the first experiment, i.p. alcohol (1 g/kg) did not increase 3-MT levels in any of the brain areas
studied but decreased 3-MT levels significantly in the nucleus accumbens of the ANA rats. HVA
concentrations were elevated by alcohol in the nucleus accumbens of the AA rats and in the
striatum (caudate-putamen) of both AA and ANA rats. The HVA concentrations were slightly
but significantly larger in the nucleus accumbens of the ANA rats than in the AA rats, and both
DOPAC and HVA concentrations were larger in the striatum of the AA rats than in the ANA
rats. In the second experiment, where the pargyline-induced accumulation of 3-MT was assessed,
alcohol significantly decreased 3-MT levels relative to the controls in the nucleus accumbens,
and there was also a tendency for a decrease in other brain regions studied. The blood alcohol
concentrations did not differ between the rat lines after i.p. administration.
5.3. Effects of voluntary alcohol consumption on dopamine release and metabolism in the AA
rats (III)
Following a voluntary alcohol drinking session, all dopamine metabolites, including 3-MT, were
elevated in the caudate putamen and olfactory tubercle, while in the nucleus accumbens only the
3-MT concentration was increased. However, in the animals given water in the tubes in which
they previously had received alcohol, dopamine metabolites were increased in the caudate-
putamen but not in the nucleus accumbens and olfactory tubercle.
In this study, blood alcohol concentrations were significantly smaller than those after a
comparable dose given i.p. (7 mM vs. 24 mM, respectively). Significant correlations were found
between blood alcohol concentrations and 3-MT levels in the olfactory tubercle and also between
the amount of water consumed (in ml) and 3-MT levels in the caudate putamen (Fig. 5.3.). A
tendency for correlation was found between blood alcohol concentration and 3-MT levels in the
caudate putamen.
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Figure 5.3. Correlation between blood alcohol concentrations (BAC) and of 3-
methoxytyramine concentrations (3-MT) (A) and correlation between amount of water
consumed and 3-MT concentrations (B) in various brain regions 20 min after initiation of
drinking. Correlations were calculated wih the linear regression analysis (n=7-9).
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5.4. Effects of acute and repeated treatment with alcohol, cocaine or morphine on locomotor
activity of the AA and ANA rats (IV)
Intraperitoneal administration of alcohol did not acutely or repeatedly alter the locomotor
activity of the AA and ANA rats. Acutely cocaine-induced locomotor activity did not differ
between the AA and ANA rats with any of the doses used, but it was larger in both lines than the
cocaine-induced stimulation in the Wistar rats. Following repeated treatment, the AA rats were
sensitized to cocaine already at a dose of 10 mg/kg while in the ANA and Wistar rats
sensitization was seen only with a dose of 20 mg/kg. In fact, horizontal locomotor activity was
decreased in the AA and ANA but not in the Wistar rats following repeated treatment with 20
mg/kg of cocaine, which was most likely due enhancement of stereotyped behaviour competing
with the ambulatory activity.
Morphine induced a locomotor stimulation in all rat lines at a dose of 1 mg/kg, but the response
was larger in the AA rats than in the animals of the other lines. Furthermore, during 4-day
treatment the AA rats but not the rats of other lines showed sensitization to the locomotor
activity increasing effect of the morphine dose of 1 mg/kg but not to that of 3 mg/kg. The ANA
and Wistar rats were not sensitized to any of the morphine doses studied during the 4-day
treatment. The morphine concentrations in the plasma of the AA and ANA rats did not differ but
the morphine levels in brain and those of its metabolites both in the plasma and brain were below
the detection limits of the methods used.
5.5. Effects of acute morphine on metabolism and release of dopamine and serotonin in the
brains of the AA, ANA (V) and Wistar rats
The concentration of dopamine was larger in the caudate-putamen of the AA rats than ANA rats.
In contrast, 3-MT levels were smaller in the caudate-putamen and nucleus accumbens of the AA
rats than ANA, while the concentration of 5-HT was higher in the caudate putamen of the AA
rats than ANA rats. DOPAC, HVA or 5-HIAA concentrations did not differ in any of the brain
regions between the AA and ANA rats.
Acute treatment with morphine increased dopamine metabolism and released dopamine more in
the caudate-putamen of the AA rats than that of the ANA rats, but there were no strain
differences in this effect in the nucleus accumbens or olfactory tubercle. Morphine elevated
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levels of 5-HIAA in all brain areas studied in the AA rats but it had no significant effect on 5-
HIAA in the ANA rat brains.
Table 5.3. The concentrations of dopamine metabolites (DOPAC, HVA ,3-MT) and 5-HT
and its metabolite 5-HIAA in different brain areas of the Wistar rats following saline
(SAL) or morphine (MO 3 mg/kg) treatment
Concentration (ng/g)
DOPAC HVA 3-MT 5-HT 5-HIAA
Caudate-Putamen
SAL 1180 ± 60 720 ± 40 16.3 ± 0.6 450 ± 20 450 ± 10
MO 2120 ± 180** 1250 ± 60** 20.6 ± 1.1** 480 ± 30 560 ± 10*
Nucleus accumbens
SAL 1260 ± 100 600 ± 30 6.1 ± 0.2 1250 ± 50 660 ± 30
MO 1850 ± 290** 1250 ± 80** 8.4 ± 0.3** 1320 ± 60 840 ± 30**
*P < 0.05 and **P < 0.01, Student’s t-test (n = 7 or 8).
In the Wistar rats, DOPAC concentrations in the caudate-putamen and nucleus accumbens were
higher than in the AA and ANA rats (Table 5.3.). Similarly to the situation in the ANA rats, 3-
MT concentration in the caudate-putamen of Wistar rats was smaller than in that present in the
AA rats. Furthermore, the 5-HT concentration in the caudate-putamen was lower than in the AA
rats.
Morphine (3 mg/kg) elevated the concentrations of all dopamine metabolites and 5-HIAA both
in the caudate-putamen and nucleus accumbens of the Wistar rats (Table 5.3.), indicating that the
effects of morphine in this rat line were similar to those found in the AA rats. Table 5.4.
summarises the differences in the effects of morphine between the AA, ANA and Wistar rats.
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Table 5.4. Summary of the differences in the morphine-induced elevations of dopamine and
5-HT metabolite concentrations in the caudate putamen and nucleus accumbens of the AA,
ANA and Wistar (Wis) rats.
Brain
region/dose 3-MT DOPAC HVA 5-HIAA
Caudate-putamen
1 mg/kg AA > ANA AA > ANA AA > ANA AA > ANA
3 mg/kg Wis ≈ AA > ANA Wis ≈ AA > ANA Wis ≈ AA > ANA Wis ≈ AA > ANA
Nucleus accumbens
1 mg/kg AA ≈ ANA AA ≈  ANA AA ≈ ANA AA > ANA
3 mg/kg Wis ≈ AA ≈ ANA Wis ≈ AA ≈ ANA Wis ≈ AA ≈ ANA Wis ≈ AA > ANA
6. DISCUSSION
6.1. Steady-state 3-MT concentrations in the estimation of dopamine release
The actions of both morphine and haloperidol on steady-state 3-MT concentrations in brain
tissue differed depending on the method by which the animals were sacrificed. When the animals
were killed by microwave irradiation, the results obtained were in line with those found by using
in vivo microdialysis with freely moving animals (Zetterström et al. 1983, Di Chiara and
Imperato 1988). Thus these results support those of Karoum et al. (1992), who reported that
haloperidol does increase the steady-state 3-MT concentrations both in the striatum and nucleus
accumbens of rats.
Although some COMT activity could be detected in microwave-irradiated tissues, it had no
effect on the concentrations of dopamine or its metabolites post mortem. 3-MT is not readily
degraded by the temperatures present in brains after microwave irradiation, and it is also resistant
to the oxidation (Ikarashi et al. 1985), so it is possible that 3-MT concentrations measured in the
present study are close to those present in brains in vivo.
In previous studies, haloperidol (Gropetti et al. 1978; Karoum and Egan 1992; Waldmeier et al.
1981) or morphine (Wood and Rao 1991; Yonehara and Clouet 1984) have sometimes increased
or  decreased 3-MT levels. One possible explanation to the contradictory findings is the different
types of microwave irradiators that have been used. In the former studies, microwave devices
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that concentrate the electric field component of the microwave irradiation on the brain were
used. An electric field is apparently more efficient than magnetic field, but it also results in less
uniform heat distribution in the brain and it readily produces marked structural changes in brain
tissue (Blank et al. 1979; Ikarashi et al. 1986). Here we used a microwave apparatus, which
focuses the magnetic field component of the microwave irradiation to the target producing more
uniform heat distribution in the brain. This also enabled us to utilize shorter irradiation times and
apparently we achieved more rapid inactivation of enzymes (Ikarashi et al. 1984; Ikarashi et al.
1985).
The present results, thus, strongly support the idea that by assessing the steady-state 3-MT levels
in brain tissue it is possible study alterations in dopaminergic transmission. However,
prerequisite for this is that post mortem COMT activity is blocked rapidly in order to prevent
artefactual elevation of 3-MT concentration.
In comparison with so called in vivo methods, such as microdialysis or voltammetry, there are,
of course, disadvantages in the assessment of dopamine function with 3-MT. For instance, it is
not possible to get information on the time course of drug-induced alteration in neurotransmitter
release in one animal. Furthermore, with in vivo methods it is possible to follow phasic changes
in dopamine release associated with certain behaviours of an animal or changes in drug
concentration in the blood (Gratton and Wise 1994; Kiyatkin and Gratton 1994; Ranaldi et al.
1999). Therefore, these methods are superior in studies into the roles of neurotransmitters during
different  behaviours or pharmacological challenges. However, these methods also have their
own problems, e.g. in microdialysis it is necessary to cause some tissue damage in the brain area
under examination. With in vivo electrochemical methods, it is difficult exclude the possiblity
that more than one chemical species in the brain contributes to the signal recorded (Salamone
1996).
However, with adequately performed 3-MT measurements, it is possible to study dopaminergic
transmission simultaneously from several brain areas and from animals that have not
experienced surgery and anaesthesia. This allows, for instance, comparison of responses of
dopamine system in different brain areas to a certain treatment or behaviour in experimentally
naïve animals (e.g. III, V). Furthermore, with 3-MT measurements it is possible to get
information about drug effects on the dopamine system quite fast, so this method could be
especially suitable for screening the effects of new pharmaceutical compounds on dopamine
mechanisms. The best approach would be, of course, to use several of these methods in parallel.
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6.2. Different dopamine metabolites as indices of sensitization of dopaminergic transmission
The chronic morphine-treatment protocol used in this study has been shown to induce
sensitization of both nigrostriatal and mesolimbic dopamine systems to acute morphine challenge
(Attila and Ahtee 1983). The results of this experiment, thus, indicate that morphine-induced
sensitization of dopaminergic systems can be detected by measuring 3-MT. In the limbic
forebrain, the morphine-induced elevation of 3-MT levels was over two-fold in morphine rats in
comparison with repeatedly saline-treated controls. It is to be noted that in the acute experiments,
the elevation of 3-MT was not dose-dependent in the caudate-putamen (Fig. 5.2). However, in
the limbic forebrain, an acute 10 mg/kg dose of morphine did not induce maximal elevation in 3-
MT levels (data not shown). The explanation for the lack of dose-response in the caudate-
putamen may be that higher doses started to activate µ-opioid receptors that inhibit dopamine
release in that brain region (Piepponen et al. 1999; Rossetti et al. 1990; Widdowson and Holman
1992). Therefore, one possible mechanism underlying the sensitization of dopamine release in
the caudate-putamen to acute morphine administration might be localized tolerance developing
to morphine-induced inhibition of dopamine release (Piepponen et al. 1999).
The effects of morphine on DOPAC and HVA levels were similar in previously saline- and
morphine treated animals. In the caudate-putamen, however, the HVA concentrations were more
elevated in the animals withdrawn from repeated morphine treatment than in the saline-treated
animals, a result which is in line with the earlier findings (Ahtee 1974), while 3-MT
concentration indicated only minor sensitization. Given that dopamine concentrations were not
altered by chronic or acute morphine treatments, these findings suggest that the effects of
morphine on dopamine synthesis and metabolism are enhanced, while dopamine release is only
slightly increased on morphine-withdrawn rats. It is, therefore, possible that chronic morphine-
treatment may have differential effects on limbic and striatal dopaminergic functions.
6.3. Alcohol-induced alterations in dopamine metabolism and release
Given the earlier results from microdialysis experiments (Blomqvist et al. 1993; Imperato and Di
Chiara 1986; Yoshimoto et al. 1991) the result that acute i.p alcohol did not increase 3-MT
concentrations but rather decreased it, was rather surprising. There are previous reports about
alcohol-induced decrease of brain 3-MT concentrations (Hunt and Majchrowicz 1983; Liljequist
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and Carlsson 1978), but in those studies post mortem changes of 3-MT levels were not
prevented, which raises questions  about the validity of those results. The fact that the same
alcohol dose increased DOPAC and HVA levels, especially in the AA rats makes these results
even more difficult to interpret, although, there are several examples of dissociation between the
changes in synthesis and release of dopamine (e.g. Miu et al. 1992). Furthermore, it has been
recently reported that the same alcohol dose increases extracellular dopamine levels both in the
AA and ANA rats (Kiianmaa et al. 1995; Nurmi et al. 1996). However, it is also clear that the
findings from 3-MT studies are in line with the behavioural studies showing that i.p. alcohol
does not stimulate the motor activity of the AA and ANA rats (Päivärinta and Korpi 1993) and
V).
The possible weakness of the method used in the assessment of dopamine release (measurement
of 3-MT) is unlikely to be the reason for these results. Extensive studies conducted earlier
(Wood and Altar 1988) and the evaluation of the 3-MT method as a part of the present studies
indicate that tissue changes in 3-MT levels reliably reflects changes in extracellular dopamine
levels. In addition, the result that voluntary alcohol drinking elevates the 3-MT level suggests
that alcohol does not interfere with the uptake and enzymatic processes involved in the formation
of 3-MT.
Since the complete dose- and time-dependence of alcohol effects on 3-MT could not be studied
due to a shortage of animals, it is possible that 3-MT levels would be increased by some alcohol
doses and/or at some time following i.p. alcohol administration. In many studies the largest
increase accumbal dopamine release has been observed with a dose of 1.0 g/kg or higher
(Kiianmaa et al. 1995; Mocsary and Bradberry 1996; Yoshimoto et al. 1991; Yoshimoto et al.
1992, see also: Blanchard et al. 1993). Furthermore, the peak of dopamine release has usually
occurred later than 20 min following alcohol administration (e.g. Philpot and Kirstein 1998).
Therefore, it could be possible that by using a larger alcohol dose than 1 g/kg and by assessing 3-
MT concentrations later, e.g. 40 min after i.p. alcohol treatment, an elevation of 3-MT
concentration might be found.
However, given that the aim of these studies was to explore those neuronal mechanisms that
contribute to the regulation of alcohol drinking and especially to the differential alcohol drinking
of the AA and ANA rats, the relevance of these possible effects is questionable. First, it has been
shown that alcohol produces its reinforcing effects during the ascending phase of the BAC curve,
i.e. during the first 20 min following alcohol treatment or ingestion (Reid et al. 1985, Lewis and
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June 1990). Second, utilisation of larger doses would be problematic, since they produce much
higher BACs than rats could ever achieve by voluntary alcohol drinking.
In line with the present studies, voluntary alcohol drinking and experimenter-administered
alcohol (e.g. i.p.) have been shown to produce different behavioural and neurochemical effects.
For instance, although it is well established that oral alcohol is reinforcing in rats, alcohol-
induced conditioned place preference (CPP) has been produced only after very extensive
conditioning or in animals with a previous alcohol drinking history (Van der Kooy et al. 1983,
Asin et al. 1985, Bozarth 1990, Reid et al. 1985). The effects of i.p. alcohol on intracranial
electrical self-stimulation are also equivocal (Schaefer and Michael 1987, Bain and Kornetsky
1989, Kornetsky et al. 1988), while voluntary alcohol drinking has been shown to be facilitate
self-stimulation in rats (Bain and Kornetsky 1989). Furthermore, alcohol injected
intraperitoneally and alcohol consumed voluntarily have induced different changes regional
activation of rat brain as assessed with the 6-deoxyglucose method (Williams-Hemby et al. 1996;
Williams-Hemby and Porrino 1994).
There are several possible reasons for these differences, one being the slower absorption rate of
alcohol from the gastrointestinal tract in comparison with quick absorption from intraperitoneally
injected bolus. Orally ingested alcohol results in considerably longer ascending phase of BAC
curve (Nurmi et al. 1994). Thus, it is possible that acute alcohol, administered i.p., rapidly
increases blood alcohol concentration but not dopamine release, while voluntary alcohol
drinking producing a slow increase in blood alcohol concentration accelerates dopamine release.
This idea is supported by recent study by Ciccocioppo et al. (1999), which shows that
intragastric administration of alcohol (0.7 and 1.5 g/kg) via permanent catheter induces
conditioned place preference in Marchigian Sardinian alcohol-preferring rats, a line of rats,
which is derived from SP rats. In the same study, intragastric administration of alcohol by
gavage or intraperitoneal alcohol were without effect. This study suggests that intragastric
alcohol is reinforcing in these rats but stress or other factors mask this effect when other means
of administration are used.
There is also other evidence suggesting that the possibility to control drug effects or brain-
stimulation is in itself a critical factor determining the reinforcing property of the stimuli. It has
been shown that intracranial self-stimulation, which is rewarding in an animal, is less preferred
when administered with the same pattern by the experimenter (Ettenberg et al. 1981; Faricloth
1974; Tsang and Stutz 1984). Furthermore, self-administration of i.v. cocaine induces greater
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dopamine release than administration of the same cocaine doses in corresponding patterns in
yoked animals (Hemby et al. 1997).
Long lasting alcohol exposure during acquisition of alcohol drinking behaviour causes
neuroadaptive changes in brain that may result in tolerance to the alcohol's aversive effects
and/or potentiate its rewarding effects (Buck and Harris 1991; Tabakoff et al. 1996). A recent
report by Nestby et al. (1999) demonstrated that voluntary alcohol drinking induces changes in
striatal neurochemistry that are partly similar to those induced by repeated opioid or
psychostimulant administration. For instance, electrically evoked dopamine release from the
nucleus accumbens slices was enhanced in rats with alcohol drinking history and D1-receptor
mediated signalling was increased in the caudate-putamen. Furthermore, there is evidence that
chronic alcohol consumption induces sensitization, at least to the stimulatory effects of
psychostimulants and dopamine infused locally into the nucleus accumbens (Liljequist 1978;
Manley and Little 1997). The latter finding is consistent with the results of Nestby et al. (1999)
indicating that also postsynaptic mechanisms are affected by chronic alcohol consumption. Thus,
a possible reason for different effects on dopamine release after voluntary alcohol drinking and
experimenter-administered alcohol in the AA rats found in the present study could be the
development of sensitization of dopaminergic transmission towards alcohol.
In summary, on the basis of the present results, it is not possible to conclude why the dopamine
release was enhanced by alcohol drinking but not by intraperitoneal alcohol in the AA rats. It is
clear that before any of the possible explanations suggested above can be accepted they need to
be experimentally evaluated in further studies. For instance, the role of the absorption rate of
alcohol could be studied by exploring the changes in dopamine release following intravenous or
intragastric alcohol infusions at different rates. The data available as reviewed above, however,
indicates that the further evaluation of i.p. alcohol on 3-MT levels do not increase our knowledge
about the mechanism contributing to the differential alcohol drinking behaviour in the AA and
ANA rats. Therefore, one must to keep in mind that in attempts to search for neurobiological
correlates of high or low alcohol drinking the critical factors may not be found by examining
biochemical changes induced by experimenter-administered, e.g. intraperitoneally injected,
alcohol (Crabbe et al. 1990).
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6.4. Changes in dopamine functions induced by drinking session
The increase of dopamine release in the nucleus accumbens and olfactory tubercle following
voluntary alcohol ingestion suggests that these areas are involved in the motivational effects of
alcohol. Especially, the present work (III) showed that, in addition to nucleus accumbens,
alcohol drinking increases dopamine release in the olfactory tubercle as well. A significant
correlation between dopamine release and BACs was found in that brain area, but this was
interpreted to be due to a single rat with the highest drinking, BAC and dopamine release (Fig.
6.3.). Interestingly, Quarfordt and associates (Quarfordt et al. 1991) have reported that lesions of
dopaminergic neurons by 6-OHDA in both nucleus accumbens and olfactory tubercle modulate
alcohol drinking in rats.
It is interesting that the drinking session itself, i.e. access to the extra fluid tubes normally
containing alcohol strongly increased dopamine release in the caudate-putamen. Since
dopaminergic mechanisms in the dorsal striatum are implicated in the motor performance, e.g.,
in the motor co-ordination and response initiation (Amalric and Koob 1993; Robbins et al. 1989;
White 1989), it could be speculated that increased dopamine release in that brain region is
associated with motor processes during drinking behaviour. However, there is evidence that
orofacial movements involved in the ingestive behaviour are regulated by the ventrolateral
striatum (Salamone 1992; Salamone et al. 1993), the brain area that apparently was not included
in the samples dissected in the present work as they mainly consisted of dorsal striatum (see
section 4.2.). In addition, the amount of fluid consumed by water drinking animals was much
smaller than that by alcohol drinking animals, although the enhancement of dopamine
metabolism in the dorsal striatum was similar in both groups. Therefore, it is unlikely that the
increase of dopamine metabolism in this brain area would be related to orofacial or other motor
control during drinking.
Another explanation for increased activity of dopaminergic mechanisms during water drinking
may be related to the involvement of the caudate-putamen in initiation and regulation of habits or
stimulus-response associations. As reviewed in section 2.1, the findings, for instance, by Schulz
and associates  (Mirenowicz and Schultz 1996; Schultz et al. 1997) indicate that in some cases
dopaminergic neurons respond to a novel, rewarding stimulus, but the activation of neurons
fades when the animal learns to expect the reward. After the learning, the environmental cues
predicting or contingent upon reward are able to activate nigral dopamine neurons (Schultz et al.
1997).
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It is also evident that conditioned environmental stimuli associated with the availability of the
drug are important in the regulation of drug use and reinforcement (Falk and Lau 1995; Panlilio
and Schindler 1997). Therefore, it is possible that dopamine in the caudate-putamen has an
important role in the initiation of alcohol drinking and it is not surprising that cues related to the
availability of alcohol are able to activate dopaminergic transmission in this brain area.
6.5. Morphine- and cocaine-induced psychomotor stimulation and sensitization and dopamine
6.5.1. Differential morphine- and cocaine-induced behavioural sensitization in AA and ANA
rats.
One of the main findings of these studies was that the alcohol-preferring AA rats are more
susceptible to the development of behavioural sensitization following repeated short-term
treatment with morphine and cocaine than the alcohol-avoiding ANA and non-selected Wistar
rats. In addition, acutely administered morphine, but not cocaine, induced a larger locomotor
stimulation in the AA rats than in the other rats studied. There is indirect evidence that greater
efficacy of morphine in the AA rats as compared with the ANA rats is not related to different
pharmacokinetics of morphine between the rat lines. First, there was no difference in the plasma
morphine concentrations after administration of morphine (IV) indicating that the bioavailability
of the drug did not differ between the rat lines. Second, the AA and ANA rats lines differ also in
their response to the µ-agonist DAMGO given repeatedly intracerebroventricularly, i.e. AA rats,
but not the ANA rats show sensitization to repeated DAMGO (Honkanen et al. 1997). Third, the
analgesic effects of morphine do not differ between these rat lines (Honkanen et al. 1995).
Therefore, it is unlikely that differential behavioral effects of morphine between the rat lines
would result from different access of morphine into the brain.
These findings demonstrate that there are functional differences in the central opioid systems
between the AA and ANA rats, and in the case of morphine-induced stimulation and
sensitization, the AA rats differ also from non-selected Wistar rats. Furthermore, these data
suggest that mechanisms possibly involved in motivational effects of acute and repeated
treatment with drugs of abuse differ between the AA and ANA rats. If the extent of stimulation
and sensitization reflects the reactivity of these neuronal mechanism, it seems that these systems
are more activated in the AA rats than in the ANAs and Wistars by morphine and cocaine.
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Studies on the effects of repeated cocaine and morphine treatments on dopamine functions in the
AA and ANA rats are in progress (Mikkola et al. 1997; Piepponen et al. 1997).
As reported in paper III and discussed in previous sections, alcohol drinking activates these
mechanisms, i.e. mesolimbic dopamine release, in the AA rats. Therefore, it is possible that the
properties of brain dopaminergic neurons or other systems linked to them can contribute to the
high alcohol-preference of these rats. As reviewed in section 2.10.5, there are several molecular
changes in brain that may be involved in the development of behavioural sensitization. Whether
some of those mechanisms differ between the AA and ANA rats is not known and clearly could
form the basis for further studies. For instance, the changes in dopaminergic system following
repeated drug treatments should be assessed as well as the function of glutamatergic and
GABAergic mechanisms (transmitter release and receptors) associated with neuronal pathways
regulating the psychomotor effects of the drugs. Another interesting subject of study would be
G-protein functions and other intracellular signalling mechanisms that are known to change
following repeated treatments.
6.5.2. Basal levels of dopamine, 5-HT and their metabolites in AA, ANA and Wistar rats
Differences found in the basal levels of monoamines and their metabolites were rather similar to
those found earlier (Ahtee and Eriksson 1972; Ahtee and Eriksson 1973; Ahtee and Eriksson
1975; Korpi et al. 1988). However, the new finding that 3-MT levels are lower in the caudate-
putamen and nucleus accumbens in the AA rats than in the ANA or Wistar rats suggests that
dopaminergic transmission may be decreased in the AA rats. Low dopaminergic activity has
been linked to high alcohol consumption both in experimental animals and humans (George et al.
1995; McBride et al. 1995; Tiihonen et al. 1995; Volkov et al. 1996). Although there is evidence
that D2 receptor density is lower in the striatum of alcoholics than in controls, it seems that
presynaptic neuronal activity, i.e. dopamine synthesis capacity and dopamine release may be
enhanced in alcoholics (Hietala et al. 1994; Tiihonen et al. 1998).  Therefore, it is possible that
altered dopaminergic transmission might contribute to the high alcohol-preference of the AA rats
as well. It is to be noted that in microdialysis studies no baseline differences in the extracellular
levels of dopamine have been found (Kiianmaa et al. 1995; Nurmi et al. 1996). Furthermore,
there are no clear differences in the concentrations of other dopamine metabolites between the
AA and ANA rats. Therefore, additional studies are needed to exclude other possible
explanations for the low 3-MT levels, such as regional differences in COMT activity between the
rat lines.
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6.5.3. The morphine effects on mesolimbic system
The results from behavioural studies, thus, suggest that acute blockade of dopamine reuptake by
cocaine produces a similar increase in extracellular dopamine in the AA and ANA rats.
Furthermore, these results suggest that the effects of activation of postsynaptic DA receptors on
behaviour are similar in the AA and ANA rats as indicated by the result that the effects of acute
administration of cocaine are the same in both rat lines. Therefore, one possible site where the
actions of morphine could differ between the rat lines is the VTA, where morphine could induce
a greater activation of dopaminergic neurons or the nucleus accumbens where it can cause
greater inhibition non-dopaminergic pathways projecting to the VP. The biochemical evidence
(V) suggests that the latter possibility is more likely, since morphine-induced accumbal
dopamine release and metabolism do not differ in the AA and ANA rats. The low basal
dopamine release in both the caudate-putamen and nucleus accumbens of the AA rats may also
contribute to the large locomotor stimulation evoked by morphine, since there is evidence that
chronic attenuation of dopaminergic tone by 6-OHDA lesion or blockade of DA receptors
enhances the stimulatory effects of µ-opioids (Churchill et al. 1998; Stinus et al. 1992).
6.5.4. The morphine effects on nigrostriatal system
The nigrostriatal pathway was found to be more sensitive to morphine in the AA rats compared
to the ANA rats (V) as indicated by greater elevation of dopamine metabolites concentrations in
the caudate-putamen of the AA rats. Although a typical response to the activation of the
nigrostriatal pathway is expression of stereotyped behaviour (Joyce and Iversen 1979; Morelli et
al. 1989), there is some evidence that µ-opioids may induce horizontal locomotor activity also in
the SN via a specific sub-population of µ-receptors (Morelli et al. 1989). Thus, it is possible that
the large morphine-induced dopamine release in the caudate-putamen of the AA rats as
compared to ANAs underlies the larger locomotor stimulation in the animals of the former strain.
These findings may be related to those of Soini et al. (Soini et al. 1998) showing that the µ-
receptor density in the SNr is higher in AA than ANA rats. The pars reticulata neurons are
mainly GABAergic and they have an inhibitory control over the dopaminergic neurons located in
the SNc (Pucak and Grace 1994). It is likely that morphine-induced excitation of dopaminergic
neurons results from inhibition of pars reticulata inhibitory neurons. Therefore, a dense µ-
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receptor concentration in the pars reticulata neurons of the AA rats might induce greater
inhibition of GABA neurons, more extensive activation of dopaminergic neurons and
subsequently stronger locomotor stimulation than in the ANA rats.
6.5.5. The effects of morphine on metabolism of 5-HT
The difference in the brain 5-HT levels in the AAs and ANAs were found already in the
beginning of 1970’s (Ahtee and Eriksson 1972; Ahtee and Eriksson 1973) suggesting that this
neurotransmitter might play a role in the differential alcohol preference of these rats. One has to
bear in mind that little evidence about functional differences in the 5-HT system between the AA
and ANA rats have been found. The greater morphine-induced stimulation of metabolism of 5-
HT in the AA in comparison with the ANA rats, however, may indicate that this neurotransmitter
system plays a role in the differential alcohol-preference of these rat lines.
6.6. Possible role of susceptibility to sensitization in the learning of alcohol drinking
behaviour
Although it seems to be clear that dopaminergic mechanisms are important in reinforcement
processes and sensitization, the exact role of dopamine in motivated behaviour is not clear (see
section 2.5.). The results of the present study suggest that in the AA rats, the stimulatory effects
of opioids are very strong and mechanism(s) mediating the reinforcement process, e.g., possibly
mesolimbic dopaminergic pathway, will be sensitized quickly during repeated activation of
opioid receptors. Thus, alcohol drinking, which would release endogenous opioids, sensitizes the
dopaminergic system of the AA rats rapidly and the animals would become highly motivated to
seek out alcohol (Robinson and Berridge 1993). Accordingly, susceptibility to sensitization
might also result in high voluntary intake of aqueous solutions of etonitazene and cocaine
(Hyytiä and Sinclair 1993).
However, all of the experimental evidence available does not entirely support these ideas, since
AA and ANA rats do not differ in the operant intravenous self-administration of heroin and
similarly there is no difference in the breaking points in the progressive ratio-schedule (Hyytiä et
al. 1996). The largest difference in heroin self-administration between the AA and ANA rats was
the finding that the AA rats learn to press lever for heroin much quicker than the ANA rats.
Similarly, the AA rats develop alcohol preference faster than Wistar rats (e.g. Sinclair et al.
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1992a). In the AA rats, the rapid initiation of alcohol drinking may be due to enhanced ability to
learn this behaviour.
Brain dopaminergic system has been suggested to play an important role in the regulation of
reward-dependent learning (Di Chiara 1995; Schultz et al. 1997). Furthermore, it has been
speculated that the sensitization might play a role, especially in the learning of self-
administration behaviour (Altman et al. 1996; Schenk and Partridge 1997). These hypotheses are
supported by the finding that 6-OHDA lesion of the nucleus accumbens prevents the acquisition
of alchol drinking behaviour in the P rats but does not affect already learned alcohol drinking
behaviour (Ikemoto et al. 1997). The idea that sensitization might be important in the learning
phase of drug self-administration behaviour is also supported by the very fast sensitization of the
AA rats in the paradigm, where the conditioning and context-dependency of drug effects
probably have an important role. The significance of conditioning is indicated by the fact that the
response to saline injection was slightly enhanced in the AA rats following repeated morphine
treatment as compared to the response to the first saline injections (IV).
The results from experiments conducted with other rodent lines differing in their oral intake of
alcohol suggest that susceptibility to context-dependent drug-induced behavioural sensitization
may be associated with high alcohol intake. Alcohol-preferring inbred Lewis rats show a larger
behavioural sensitization following 5-day daily cocaine treatment than Fischer rats in this
paradigm in which conditioning is likely to be important (Kosten et al. 1994). Furthermore
alcohol-avoiding DBA mice develop larger context-independent behavioural sensitization to
amphetamine than the alcohol-preferring C57 mice, while the C57 mice show greater context-
dependent sensitization to amphetamine than the DBA mice (Cabib 1993). However, this finding
has not been confirmed by others (e.g. Phillips 1997; Phillips et al. 1994). Nevertheless, the
evidence from these rodent lines together with that from the AA and ANA rats suggest that
enhanced preference for oral drug-intake is associated with greater susceptibility to drug-induced
conditioning. The idea is supported by the results from the studies by (Jodogne et al. 1994) with
HR (high responders) and LR (low responders) rats. HR rats that show high exploratory
behaviour in novel environment and quickly learn i.v. drug self-administration are also
susceptible to context-dependent amphetamine-induced behavioural sensitization.
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6.7. Possible role of nigrostriatal pathway in the high alcohol-preference of the AA rats
Two findings of the present studies implicate the nigrostriatal pathway in the regulation of
alcohol drinking. First, alcohol-related cues increased dopamine release in the caudate-putamen.
Second, the increase in dopamine release after small morphine doses is greater in the caudate-
putamen of the AA rats than in the ANA rats. It has been suggested that during prolonged drug
abuse, the drug use becomes controlled partly by mechanisms mediating stimulus-response
associations, i.e. habits (Altman et al. 1996). It is possible that the nigrostriatal dopamine system
is important in the regulation of these processes (Robbins and Everitt 1996; White 1989).
Therefore, the profound activation of this system by alcohol drinking (via endogenous opioids)
could well accelerate the formation of the stimulus-response association involved in the alcohol
drinking behaviour.
Oral self-administration of alcohol or other drugs differs probably from intravenous self-
administration of the drugs, in that the delay between the response (drinking) and its outcome,
i.e. the reinforcing drug effects in the brain, requires some time after oral delivery. It is likely
that rapid acquisition of oral drug intake occurs only if the mechanism mediating associations
between the stimuli and responses associated with availability of the reinforcer and outcomes of
those responses operate efficiently. Therefore, the behavioural and biochemical findings of the
present studies may be relevant to this phenomenon, especially in the rapid learning of alcohol
drinking behaviour of the AA rats.
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7. CONCLUSIONS
1. The 3-MT concentration in the brain can be used as index of brain dopamine release if the
post mortem changes are prevented.
2. Of all dopamine metabolites measurable in the brain, 3-MT most readily reflects the changes
in dopamine release  in the brain.
3. The mesolimbic dopamine release is selectively stimulated by alcohol intake and possibly by
post-ingestive effects of alcohol, which can contribute to the reinforcing effects of alcohol.
4. The nigrostriatal dopaminergic pathway is strongly activated by opioids and cues related to
alcohol drinking in the AA rats, suggesting that this system could play a role in the initiation
and/or learning of alcohol drinking behaviour.
5. The strong behavioural stimulation of the AA rats by morphine and the rapid sensitization of
these animals to morphine and cocaine suggest that the mechanism mediating reinforcement
may be exceptionally susceptible to the sensitizing effects of the drugs of abuse and therefore
contribute to the high alcohol intake of these animals.
6. These results support the hypothesis that susceptibility to drug-induced sensitization plays a
role in individual susceptibility to substance abuse and suggest that research into mechanisms
underlying sensitization may reveal new targets for development of pharmacological
therapies for treatment of drug dependence.
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